U.S.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

Mark One

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2025~~2026

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File No. 333-255178

TRANSUITE.ORG INC.

(Exact name of registrant as specified in its charter)

Nevada

7370

30-1129581

(State or Other Jurisdiction of

Incorporation or Organization)

(Primary Standard Industrial

Classification Number)

(IRS Employer

Identification Number)

732 S 6th St# 4304

Las Vegas NV 89101

775-295-4295

(Address and telephone number of principal executive offices)

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
(Do not check if a smaller reporting company)		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Applicable Only to Issuer Involved in Bankruptcy Proceedings During the Preceding Five Years. N/A

Indicate by checkmark whether the issuer has filed all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes ☐ No ☒

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date.

60 79,~~059~~849,~~093~~992 Shares of Common Stock as of ~~November~~June 1711, ~~2025~~2026

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1.	Unaudited Condensed Consolidated Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1523
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	1929
Item 4.	Controls and Procedures	1929
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	2030
Item 1A.	Risk Factors	2030
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2030
Item 3.	Defaults Upon Senior Securities	2030
Item 4.	Mine Safety Disclosures	2030
Item 5.	Other Information	2030
Item 6.	Exhibits	2030
SIGNATURES		2131

Table of Contents

Transuite.Org Inc.

Condensed Consolidated Balance Sheets

	September 30,			December 31,
	March 31,			December 31,
	2025			2024
	2026			2025
	(Unaudited)			(Audited)
ASSETS
Current Assets
Cash and cash equivalents	$	144,~~030~~545		$	-3,705
Fund held in trust		-			16,103
Accounts receivable		120,781			19,299
Accounts receivable		15,000			-
Other receivable		16,059			14,889
Other receivable and prepayment		16,062			-
Prepaid expense		38,710			18,757
Due from related party		-19,801			158,~~000~~901
Deferred share issuance cost		254,750			-254,750
Total Current Assets	$	~~299~~454,~~842~~646		$	31320,~~103~~301
Other Assets
Goodwill		12,501,149			-
Property and Equipment, net		41,724			17,160
Intangible assets, net		24,607,847			40,531
Total Assets	$	496,370		$	337,461
Total Assets	$	37,408,838		$	71,634
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilities	$	85160,~~353~~412		$	66109,~~367~~281
Accrued interest		14,477			3,253
Due to related parties		15,338			11,682
Due to related party		3,212			2,154
Stock payable		169,997			688,934
Convertible note		-			153,520
Total Current Liabilities		345,747			809,897
Stock payable		50,000			-
Loan payable		40,692			-
Total Current Liabilities		153,042			225,294
Total Liabilities		386,439			809,897
Loan payable		172,062			148,442
Contingent liability		22,875,281			-
Total Liabilities		23,200,385			373,736
Commitments and Contingencies (Note 12)
STOCKHOLDERS' EQUITY (DEFICIT)
Common Stock: $0.001 par value, 75,000,000 shares authorized, 47,869,093 shares and 4,046,760 shares issued and outstanding, respectively		47,869			4,047
Common Stock: $0.001 par value, 75,000,000 shares authorized, 71,783,325 shares and 61,254,427 shares issued and outstanding, respectively		71,783			61,254
Additional paid-in capital		4247,~~592~~871,~~082~~921			~~143~~46,~~843~~928,116
Accumulated deficit		(2840,~~429~~815,~~710~~538	)		(~~458~~37,~~919~~619,073	)
Total equity (deficit) attributed to Transuite.Org. Inc.		14,210,241			(311,029	)
Accumulated other comprehensive income		2,022			2,379
Non-controlling interest		(1,788	)		8,927
Less: Deferred compensation (including $23,795 and $34,890 of deferred compensation to related party, respectively)		(6,375,609	)		(9,857,820	)
Total Stockholders' Equity (Deficit)		14,208,453			(302,102	)
Less: Treasury Stock		(600,000	)		-
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	37,408,838		$	71,634
Total equity (deficit) attributed to Transuite.Org. Inc.		154,579			(485,144	)
Non-controlling interest		(44,648	)		12,708
Total Stockholders' Equity (Deficit)		109,931			(472,436	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	496,370		$	337,461

The accompanying notes are an integral part of ~~the~~these condensed consolidated financial statements.

Table of Contents

Transuite.Org Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended						~~Nine Months Ended~~
	September 30,						September 30,
	March 31,
	2025			2024			2025			2024
	2026			2025
Revenues	$	65121,~~000~~784		$	-		$	~~115,000~~		$	-
Operating Expenses
Cost of sales		12,160			-
General and administrative expenses	$	6,321		$	-		$	8,520		$	-
Gross Profit		109,624			-
Professional fees (including stock-based compensation of $20,878,790 and $0 for three months ended September 30, 2025 and 2024 and $27,938,890 and $0 for nine months ended September 30, 2025 and 2024, respectively)		20,929,582			186,797			28,050,975			271,843
Operating Expenses
Amortization		3,228			3,386			9,684			9,842
General and administrative expenses	$	15,250		$	103
Total operating expenses		20,939,131			190,183			28,069,179			281,685
Professional fees (including stock-based compensation of $3,306,511 and $408,851, respectively)		3,334,814			479,997
Net loss from operations		(20,874,131	)		(190,183	)		(27,954,179	)		(281,685	)
Professional fees - related party (including stock-based compensation of $11,096 and $0, respectively)		11,096			-
Other expense
Depreciation and Amortization		2,196			3,228
Interest expense		(4,105	)		-			(11,224	)		(3,987	)
Total operating expenses		3,363,356			483,328
Total other expense		(4,105	)		-			(11,224	)		(3,987	)
Net loss from operations		(3,253,732	)		(483,328	)
Net loss before taxes		(20,878,236	)		(190,183	)		(27,965,403	)		(285,672	)
Other income (expense)
Provision for income taxes		-			-			-			-
Interest expense		(47	)		(3,069	)
Net loss	$	(20,878,236	)	$	(190,183	)	$	(27,965,403	)	$	(285,672	)
Other expense		(111	)		-
Less: Net loss attributable to non-controlling interest		(685	)		-			(685	)		-
Other income		77			-
Net loss attributable to Transuite.Org.Inc.	$	(20,877,551	)	$	(190,183	)	$	(27,964,718	)	$	(285,672	)
Total other income (expense)		(81	)		(3,069	)
Net Loss Per Common Share – Basic and Diluted	$	(0.96	)	$	(0.05	)	$	(2.15	)	$	(0.07	)
Net loss before taxes		(3,253,813	)		(486,397	)
Weighted Average Common Shares Outstanding		21,803,604			4,046,760			13,009,081			4,046,760
Provision for income taxes		-			-
Net loss		(3,253,813	)		(486,397	)
Less: Net loss attributable to non-controlling interest		(57,348	)		(150	)
Net loss attributable to Transuite.Org. Inc.	$	(3,196,465	)	$	(486,247	)
Comprehensive loss
Net loss	$	(3,253,813	)	$	(486,397	)
Foreign currency adjustment		(365	)		-
Total comprehensive loss		(3,254,178	)		(486,397	)
Less: Comprehensive loss attributable to noncontrolling interest	(57,356		)		-
Net comprehensive loss attributed to stockholders of Transuite.Org. Inc.	$	(3,196,822	)	$	(486,397	)
Net Loss Per Common Share – Basic and Diluted	$	(0.05	)	$	(0.06	)
Weighted Average Common Shares Outstanding		69,202,911			7,579,048

The accompanying notes are an integral part of the condensed consolidated financial statements.

Table of Contents

Transuite.Org Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

For the ~~six~~three months ended ~~September~~March 3031, ~~2025~~2026 and ~~September~~March 3031, ~~2024~~2025

(Unaudited)

For ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026

	Common stock						AdditionalPaid-in			Accumulated						Non-controlling			TotalShareholders'Equity
																												Total
	Shares			Amount			Capital			Deficit			Total			Interest			(Deficit)
							Additional						Other												Non-			Shareholders'
Balance, December 31, 2024 (Audited)		4,046,760		$	4,047		$	143,843		$	(458,919	)	$	(311,029	)	$	8,927		$	(302,102	)
	Common stock						Paid-in			Accumulated			Comprehensive			Deferred			Treasury						controlling			Equity
Stock-based compensation		221,000			221			408,629			-			408,850			-			408,850
	Shares			Amount			Capital			Deficit			Income			Compensation			Stock			Total			Interest			(Deficit)
Issuance of common stock as commitment shares		135,000			135			249,615			-			249,750			-			249,750
Balance, December 31, 2025 (Audited)		61,254,427		$	61,254		$	46,928,116		$	(37,619,073	)	$	2,379		$	(9,857,820	)	$	-		$	(485,144	)	$	12,708		$	(472,436	)
Issuance of common stock for conversion of convertible note		5,117,333			5,117			148,403			-			153,520			-			153,520
Issuance of common stock for debt settlement		3,148,898			3,149			185,785			-			-			-			-			188,934			-			188,934
Net loss											(486,247	)		(486,247	)		(150	)		(486,397	)
Issuance of common stock for acquisition of Goldfinch Group Co. Ltd. HK		3,500,000			3,500			346,500			-			-			-			-			350,000			-			350,000
Balance, March 31, 2025 (Unaudited)		9,520,093		$	9,520		$	950,490		$	(945,166	)	$	14,844		$	8,777		$	23,621
Issuance of common stock to non-affiliates for services		2,550,000			2,550			342,450			-			-			-			-			345,000			-			345,000
Stock-based compensation		3,395,000			3,395			6,647,855			-			6,651,250			-			6,651,250
Issuance of common stock to SolanAI Global Ltd. as treasury stock		3,000,000			3,000			597,000			-			-			-			(600,000	)		-			-			-
Net loss		-			-			-			(6,600,618	)		(6,600,618	)		(152	)		(6,600,770	)
Cancellation of common stock issued to non-affiliates for services		(1,670,000	)		(1,670	)		(527,930	)		-			-			7,276			-			(522,324	)		-			(522,324	)
Balance, June 30, 2025 (Unaudited)		12,915,093		$	12,915		$	7,598,345		$	(7,545,784	)	$	65,476		$	8,625		$	74,101
Stock-based compensation incurred from deferred compensation		-			-			-			-			-			3,474,935			-			3,474,935			-			3,474,935
Stock-based compensation		11,954,000			11,954			20,816,836			-			20,828,790			-			20,828,790
Other comprehensive loss		-			-			-			-			(357	)		-			-			(357	)		(8	)		(365	)
Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd.		3,000,000			3,000			(3,000	)		(6,375	)		(6,375	)		(8,625	)		(15,000	)
Net loss		-			-			-			(3,196,465	)		-			-			-			(3,196,465	)		(57,348	)		(3,253,813	)
Issuance of common stock for acquisition of SolanAI Global Ltd.		10,000,000			10,000			12,489,901			-			12,499,901			(1,103	)		12,498,798
Balance, March 31, 2026 (Unaudited)		71,783,325		$	71,783		$	47,871,921		$	(40,815,538	)	$	2,022		$	(6,375,609	)	$	(600,000	)	$	154,579		$	(44,648	)	$	109,931
Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd.		10,000,000			10,000			1,690,000			-			1,700,000			-			1,700,000
Net loss		-			-			-			(20,877,551	)		(20,877,551	)		(685	)		(20,878,236	)
Balance, September 30, 2025 (Unaudited)		47,869,093		$	47,869		$	42,592,082		$	(28,429,710	)	$	14,210,241		$	(1,788	)	$	14,208,453

For ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025

	Common stock				AdditionalPaid-in		Accumulated						Non-controlling			TotalShareholders'
																Total
	Shares		Amount		Capital		Deficit			Total			Interest			Deficit
					Additional								Non-			Shareholders'
Balance, December 31, 2023 (Unaudited)		4,046,760	$	4,047	$	35,826	$	(89,398	)	$	(49,525	)	$	-		$	(49,525	)
	Common stock				Paid-in		Accumulated						controlling			Equity
Imputed interest		-		-		1,329		-			1,329			-			1,329
	Shares		Amount		Capital		Deficit			Total			Interest			(Deficit)
Net loss								(50,217	)		(50,217	)		-			(50,217	)
Balance, December 31, 2024 (Audited)		4,046,760	$	4,047	$	143,843	$	(458,919	)	$	(311,029	)	$	8,927		$	(302,102	)
Balance, March 31, 2024 (Unaudited)		4,046,760	$	4,047	$	37,155	$	(139,615	)	$	(98,413	)	$	-		$	(98,413	)
Stock-based compensation		221,000		221		408,629		-			408,850			-			408,850
Imputed interest		-		-		1,992		-			1,992			-			1,992
Issuance of common stock as commitment shares		135,000		135		249,615		-			249,750			-			249,750
Net loss								(45,272	)		(45,272	)		-			(45,272	)
Issuance of common stock for conversion of convertible note		5,117,333		5,117		148,403		-			153,520			-			153,520
Balance, June 30, 2024 (Unaudited)		4,046,760	$	4,047	$	39,147	$	(184,887	)	$	(141,693	)	$	-		$	(141,693	)
Net loss		-		-		-		(486,247	)		(486,247	)		(150	)		(486,397	)
Forgiveness of loan payable to related party		-		-		104,696		-			104,696			-			104,696
Balance, March 31, 2025 (Unaudited)		9,520,093	$	9,520	$	950,490	$	(945,166	)	$	14,844		$	8,777		$	23,621
Net loss		-		-		-		(190,183	)		(190,183	)		-			(190,183	)
Balance, September 30, 2024 (Unaudited)		4,046,760	$	4,047	$	143,843	$	(375,070	)	$	(227,180	)	$	-		$	(227,180	)

The accompanying notes are an integral part of ~~the~~these condensed consolidated financial statements.

Table of Contents

Transuite.Org Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended
	Three Months Ended
	September 30,
	March 31,
	2025			2024
	2026			2025
Cash Flows from Operating Activities:
Net loss	$	(273,~~965~~253,~~403~~813	)	$	(~~285~~486,~~672~~397	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization		9,684			9,842
Amortization on intangible assets		-			3,228
Imputed interest		-			3,321
Depreciation on property and equipment		2,196
Share-based compensation		27,938,890			-
Issuance of common stock to non-affiliates for services		345,000			408,851
Accrual of unvested incentive stock		19,997			-
Cancellation of common stock issued to non-affiliates for services		(522,324	)		-
Stock-based compensation incurred from deferred compensation		3,474,935			-
Changes in operating assets and liabilities:
Accounts receivable		(15101,~~000~~482	)		-
Prepaid Expense		(6,675	)		98,640
Other receivable		(1,170	)		-
Deferred Share Issuance Cost		(5,000	)		-
Prepaid expense		(19,953	)		(14,685	)
Accounts payable and accrued liabilities		4,071			49,992
Deferred Share Issuance Cost		-			(5,002	)
Accrued Interest		11,224			-
Accounts payable and accrued liabilities		51,131			18,789
Net Cash Used in Operating Activities		(28,209	)		(123,877	)
Accrued Interest		-			3,070
Net Cash Used in Operating Activities		(5,483	)		(72,146	)
Cash Flows from Investing Activities:
Net funds from acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd.		1,458			-
Acquisition of property and equipment		(26,521	)		-
Net Cash Provided by Investing Activities		1,458			-
Net Cash Used in Investing Activities		(26,521	)		-
Cash Flows from Financing Activities:
Proceeds from loans		5340,~~620~~692			-46,820
Repayment of loans		(30,000	)		-
Repayment to related party		(10,900	)		-
Proceed from related party		2,013			-
Advancement from related party		3,635			-
Proceeds from loan payable – related parties		23,045			163,625
Proceeds from loan payable – related party		-			9,606
Repayment of loan payable – related party		(24,000	)		-
Net Cash Provided by Financing Activities		33,427			56,426
Net Cash Provided by Financing Activities		24,678			163,625
Effect of exchange rate changes on cash		(583	)		-
Net Change in Cash and Cash Equivalents		~~(2,073~~840	)		39(15,~~748~~720	)
Cash and Cash Equivalents, beginning of period		163,~~103~~705			1016,~~815~~103
Cash and Cash Equivalents, end of period	$	144,~~030~~545		$	~~50,563~~383
Cash consists of:
Cash at bank	$	144,~~030~~545		$	~~10,815~~-
Funds held in trust		-			-383
	$	144,~~030~~545		$	~~10,815~~383
Supplemental Disclosure Information:
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-Cash Disclosure:
Forgiveness of loan payable to related party	$	-		$	104,696
Issuance of common stock as commitment shares	$	-		$	249,748
Issuance of common stock as commitment shares	$	249,750		$	-
Issuance of common stock to non-affiliates for services	$	345,000		$	-
Conversion of convertible notes payable	$	153,520		$	-
Issuance of common stock to SolanAI Global Ltd. as treasury stock	$	600,000		$	-
Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd.	$	15,000		$	-
Issuance of common stock for debt settlement	$	188,934		$	-
Issuance of common stock for acquisition of SolanAI Global Ltd.	$	12,500,000		$	-
Issuance of common stock for acquisition of Goldfinch Group Co. Ltd. HK	$	350,000		$	-
Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd.	$	1,700,000		$	-
Cancellation of common stock issued to non-affiliates for services	$	(522,324	)	$	-

The accompanying notes are an integral part of ~~the~~these condensed consolidated financial statements.

36 Table of Contents

Transuite.Org Inc.

Notes to the ~~Condensed~~ Consolidated Financial Statements

~~September~~March 3031, ~~2025~~2026

(Unaudited)

NOTE 1 - NATURE OF OPERATIONS

Transuite.Org Inc. ("“TRSO"” or the “Company”) is a Nevada~~-incorporated~~ ~~artificial~~corporation ~~intelligence~~incorporated ~~solutions provider founded~~ on June 15, 2018,. ~~with~~The ~~its~~Company’s common ~~shares~~stock is publicly traded on the OTCQB market under the ticker symbol TRSO. ~~As an SEC-reporting issuer, the company maintains a steadfast commitment to delivering sustainable value to shareholders through innovative AI technologies.~~

~~Led~~The byCompany ~~top~~is AIa ~~scientists~~technology-focused ~~and~~holding ~~powered~~company bydedicated ~~elite~~to ~~research~~developing ~~team,~~integrated ~~TRSO~~solutions ~~has~~that ~~developed~~combine ~~the~~Web3 ~~world-leading~~infrastructure, AIdigital ~~Social~~asset ~~Agent~~technologies, ~~platform.~~and ~~This~~artificial ~~groundbreaking technology integrates multimodal~~ intelligence~~, real~~-~~time~~enabled ~~translation,~~enterprise ~~deviation~~systems. ~~correction~~Through ~~learning~~strategic acquisitions, ~~knowledge fusion~~partnerships, and ~~complex~~platform ~~reasoning~~development ~~capabilities~~initiatives, ~~- creating~~ the ~~most~~Company ~~creative~~is AIpositioning ~~"super~~itself ~~employees" that deliver extraordinary value~~ to ~~enterprises.~~build ~~As the global pioneer in "AI Workforce as~~ a ~~Service"~~scalable ~~(AWaaS),~~ecosystem ~~our~~designed ~~innovative model enables enterprises~~ to ~~either~~connect ~~rent~~digital orfinancial ~~purchase~~systems AIwith ~~employees~~real-world ascommercial ~~permanent~~and ~~knowledge~~infrastructure ~~assets, setting the global standard for enterprise AI adoption~~applications.

~~TRSO~~The ~~has~~Company’s ~~established~~long-term ~~itself~~strategy ascenters aon ~~leader~~connecting indigital ~~AI-driven business solutions~~assets, ~~offering~~Web3 ~~pioneering~~blockchain AIinfrastructure, ~~Social~~and ~~Agent~~real-world ~~platforms~~assets ~~for~~(“RWA”) ~~global~~through ~~enterprises. We are dedicated to making AI workforce deployment more accessible and efficient~~compliant, ~~enabling~~enterprise-grade ~~businesses to meet growing demands for intelligent automation~~platforms. ~~Our~~Management ~~platform~~believes ~~allows enterprises to rapidly deploy industry-specific AI social agents~~ that ~~integrate~~the ~~natively~~convergence ~~with~~of ~~major~~digital ~~global~~finance, ~~platforms~~distributed ~~including WhatsApp~~infrastructure, ~~Telegram,~~ and ~~WeChat.~~intelligent ~~These~~automation ~~advanced~~technologies ~~agents~~represents ~~deliver~~a ~~24/7,~~significant ~~hyper-realistic~~growth ~~customer~~opportunity ~~interactions~~across ~~while~~global ~~automating complex business processes, ultimately driving superior operational outcomes~~markets. ~~Our mission centers on empowering organizations to build their AI workforce, enhance efficiency, and transform customer engagement through our revolutionary technology.~~

~~Building~~The ~~upon~~Company’s ~~our~~operations AIare ~~social~~currently ~~agent~~organized ~~foundation,~~around ~~TRSO~~three isprimary ~~developing~~strategic ~~a comprehensive AI ecosystem that combines multimodal intelligence, seamless social platform integration, and sophisticated~~ business process automation. This strategic expansion positions the company at the vanguard of AI innovation, addressing evolving enterprise needs across multiple sectors including healthcare, e-commerce, and education.initiatives:

~~The~~SolanAI ~~company~~– ~~benefits~~Web3 ~~from~~Payment the leadership of an internationally recognized team with roots in Tsinghua University, bringing more than ten years of specialized expertise in artificial intelligence, machine learning, natural language processing, and ~~enterprise-grade~~Digital ~~solutions.~~Asset Through our proprietary technologies and deep experience in large-scale AI model implementation, TRSO develops transformative solutions that help businesses successfully navigate the AI revolution while delivering concrete, measurable value to users worldwide.Infrastructure

OnThrough ~~November~~its 24subsidiary SolanAI Global Limited, ~~2024~~a Hong Kong-based technology entity led by experienced Web3 technology professionals, the Company ~~and~~is ~~other~~developing ~~founders~~digital ~~formed~~payment ~~Goldfinch~~infrastructure ~~Group~~designed ~~Holdings~~to ~~Ltd~~connect blockchain-based digital assets with real-world commercial payment environments. InThe ~~which~~SolanAI ~~the~~platform ~~Company~~is ~~holds~~intended to support compliant digital asset transactions, enterprise payment integration, and cross-platform settlement capabilities. This infrastructure is designed to serve as a ~~70%~~foundational ~~controlling~~bridge ~~interest~~between decentralized financial technologies and traditional business systems.

OnAUXSTO ~~August~~– 8,Digital ~~2025,~~Asset ~~the~~Exchange ~~Company~~and ~~entered~~Financial into a share exchange agreement with Fidelity World Holdings Ltd. for the acquisition of the remaining 30% equity interest in Goldfinch Group Holdings Ltd. through the issuance of 3,000,000 restricted common shares at $2.00 per share with a fair of $6,000,000. Upon the completion of the transaction, the Goldfinch Group Holdings Ltd. become wholly owned subsidiary of the Company.Infrastructure

OnThe ~~August 25, 2025, the~~ Company has entered into astrategic ~~share~~cooperation ~~exchange~~arrangements ~~agreement~~ with ~~Crestar~~Australian ~~Holdings~~Fintech ~~Ltd., wholly owned subsidiary of Goldfinch~~ Group ~~Holdings~~Pty Ltd., ~~and~~(“AFT ~~Hailiang Li for the acquisition of 51% equity interest in SolanAI Global Ltd.~~Group”), a ~~Hong~~global ~~Kong AI~~ technology-finance ~~company,~~group ~~through~~headquartered ~~the~~in ~~issuance of 10~~Sydney,~~000,000~~ ~~restricted common shares at $1~~Australia.25 ~~per~~Under ~~share~~these ~~with a fair value of $12~~arrangements,~~500,000~~ asthe ~~initial~~parties ~~consideration.~~intend ~~The Company may issue up~~ to ~~5,000,000~~engage ~~additional~~in ~~shares~~long-term ~~based~~strategic oncollaboration ~~independent~~in ~~SolanAI’s~~the ~~valuation~~areas ~~completed~~of ~~within~~Web3 ~~120~~financial ~~days~~infrastructure, ~~subject~~digital topayment ~~Board~~systems, ~~approval~~ and ~~additional~~digital ~~SEC~~asset ~~disclosure.~~trading Onplatform ~~August 25, 2025, the Company completed the acquisition of 51% of SolanAI~~development.

4In ~~Table~~addition, ofthe ~~Contents~~Company has entered into an arrangement to acquire a 51% equity interest in AEEC International Pty Ltd. (formerly known as Australian Equity Exchange Center Pty Ltd.) (“AEEC”), which operates under the brand name AUXSTO. The AUXSTO platform is an Australia-based digital asset trading and technology infrastructure provider focused on delivering compliant digital asset trading services, liquidity support, and fiat currency on-ramp and off-ramp capabilities.

OnAEEC ~~September~~has ~~15,~~represented ~~2025,~~that ~~the~~it ~~Company~~operates ~~entered~~as ~~into~~ a ~~Letter~~digital ofasset ~~Intent~~service ~~(“LOI”)~~provider registered with ~~Fujian~~the ~~Wochong~~Australian ~~Intelligent~~Transaction ~~Technology~~Reports ~~Co.,~~and ~~Ltd.~~Analysis Centre (“~~Wochong~~AUSTRAC”) ~~outlining~~as a ~~proposed~~Digital ~~transaction~~Currency ~~for~~Exchange ~~the~~provider, ~~acquisition~~supporting ofregulatory ~~51%~~compliance ~~of the equity interest~~ in ~~Wochong~~anti-money ~~through~~laundering ~~the~~and ~~issuance~~counter-terrorism offinancing ~~common stock~~programs. ~~The~~Through ~~LOI~~this ~~stipulates~~cooperation ~~that~~framework, the ~~transaction~~Company ~~will~~intends ~~be executed based on the mutually agreed valuation of Wochong, which is~~ to beexpand ~~determined~~its ~~upon~~capabilities ~~completion~~in ofregulated ~~due~~digital ~~diligence.~~asset ~~The agreement is subject to several conditions~~infrastructure, ~~including~~cross-border ~~satisfactory~~settlement ~~due diligence results~~systems, ~~approval by the boards of directors of both companies, the absence of any material adverse changes,~~ and ~~obtaining all necessary third~~institutional-~~party~~grade ~~consents.~~digital ~~The~~finance ~~LOI includes mutual confidentiality provisions and grants either party the right to terminate the agreement in writing should the due diligence results prove unsatisfactory~~services.

OnGoldfinch ~~September~~– ~~26,~~Intelligent ~~2025,~~Infrastructure the Company entered into a Letter of Intent (“LOI”) with SYD GOLDX PTY LTD (“SGX”) outlining a proposed transaction for the acquisition of 51% of the equity interest in SGX, an Australian licensed Digital Currency Exchange, through the issuance of common stock. The LOI provides that the parties will negotiate in good faith to enter into a definitive agreement, subject to satisfactory completion of due diligence, negotiation of final terms, approval by the boards of directors of both companies, and ~~other~~Real-World ~~customary~~Asset ~~conditions. The LOI includes mutual confidentiality provisions and grants either party the right to terminate the agreement in writing should the due diligence results prove unsatisfactory.~~Integration

OnThrough ~~September~~its ~~30, 2025, the Company entered into a share exchange agreement with Crestar Holdings Ltd., wholly owned~~ subsidiary of Goldfinch-Chong ~~Group Holdings Ltd., and Hailiang Li for the acquisition of 100% equity interest in Xirangsheng~~ (~~Shenzhen~~Fuzhou) ~~Health~~ Technology Co., Ltd. ~~(“XRS”)~~, anthe ~~innovative~~Company ~~enterprise~~operates ~~based~~intelligent oninfrastructure ~~the~~systems ~~combination~~focused ofon AIthe ~~Social~~management ~~Agent~~ and ~~Traditional~~optimization ~~Chinese Medicine, through the issuance~~ of ~~10,000,000~~distributed ~~restricted~~energy ~~common~~and ~~shares~~charging atinfrastructure $0assets.17 ~~per~~The ~~share~~Goldfinch ~~with~~platform ais ~~fair~~designed ~~value~~to ~~$1,700,000~~support asintelligent ~~initial~~infrastructure ~~consideration.~~deployment, ~~The~~data-driven ~~Company~~asset ~~may~~management, ~~issue~~and ~~additional~~technology-enabled ~~shares~~digitization ~~within 60 days after receipt~~ of ~~the~~real-world ~~independent~~infrastructure ~~valuation~~systems. ofThese ~~XRS~~capabilities ~~upon~~align ~~terms~~with ~~agreed~~the onCompany’s ~~the~~broader ~~Agreement, subject~~strategy to ~~Board~~integrate ~~approval~~physical ~~and~~infrastructure ~~compliance~~assets with ~~applicable~~digital ~~securities~~financial ~~laws~~technologies. ~~On September 30, 2025, the Company completed the acquisition of 100% of XRS.~~

Strategic Development and Future Outlook

During the year ended December 31, 2025, the Company generated revenue primarily from strategic consulting and technology-related services that supported enterprise digital infrastructure initiatives. Concurrently, the Company executed a series of strategic acquisitions and cooperation agreements intended to expand its technological capabilities and global market presence.

Table of Contents

Management continues to focus on the integration of acquired businesses, the development of scalable infrastructure platforms, and the expansion of strategic partnerships across multiple jurisdictions. The Company’s future growth is expected to be driven by continued platform development, commercialization of digital asset infrastructure, and expansion into regulated financial technology markets.

As a developing technology holding company, the Company’s future operations depend on its ability to successfully integrate acquired entities, develop scalable technology platforms, obtain additional financing, and execute its long-term strategic initiatives in global digital infrastructure and financial technology sectors.

The Company is advancing a long-term strategy focused on building regulated digital asset infrastructure, enterprise payment connectivity, and real-world asset integration platforms across multiple markets.

The following completed acquisitions and entity formations expanded the Company’s operating platform during fiscal 2025 and the three months ended March 31, 2026.

On August 14, 2025, Crestar Holdings Ltd. was formed as a 100% subsidiary of Goldfinch Group Holdings Ltd. in which the Company indirectly has a 100% equity interest.

On August 20, 2025, the Company entered into a share exchange agreement with Fidelity World Holdings Ltd. for the acquisition of the remaining 30% equity interest in Goldfinch Group Holdings Ltd. through the issuance of 3,000,000 restricted common shares. Upon completion of the transaction, the Goldfinch Group Holdings Ltd. became a wholly owned subsidiary of the Company.

On August 25, 2025, the Company completed the acquisition of 51% of SolanAI Global Ltd. through the issuance of 10,000,000 restricted common shares as initial consideration.

On September 3, 2025, Yuan Qi (Shenzhen) AI Co., Ltd. was formed as a 100% subsidiary of Crestar Holdings Ltd., in which the Company indirectly has a 100% equity interest.

On September 16, 2025, Jiansheng (Shenzhen) Technology Co., Ltd. was formed as an 80% subsidiary of Crestar Holdings Ltd., in which the Company indirectly has an 80% equity interest. Jiansheng (Shenzhen) Technology Co., Ltd. specializes in AI application software development.

On September 29, 2025, Solan (Shenzhen) Technology Co., Ltd. was formed as a 100% subsidiary of Crestar Holdings Ltd., in which the Company indirectly has a 100% equity interest.

On September 30, 2025, the Company completed the acquisition of 100% of Xirangsheng (Shenzhen) Health Technology Co., Ltd. through the issuance of 10,000,000 restricted common shares as initial consideration.

On December 31, 2025, the Company entered into a share exchange agreement for the acquisition of 51% of Goldfinch Group Co. Ltd. (Hong Kong), which holds 100% of Goldfinch-Chong (Fuzhou) Technology Co., Ltd., through the issuance of 5,000,000 restricted common shares. As of December 31, 2025, 5,000,000 shares remained outstanding and were recorded as stock payable. From January to February 2026, 3,500,000 shares were issued with 1,500,000 shares to be issued within year 2026.

On February 21, 2026, the Company entered into a Cooperation Agreement with Honwo Technology Holding Limited (“Honwo”) to establish a strategic collaboration framework in Web3 technology and related business development.

Pursuant to the agreement, Crestar Holdings Limited, a wholly owned subsidiary of the Company, agreed to transfer a 19% equity interest in SolanAI Global Limited to Honwo while retaining majority ownership and control. In connection with this arrangement, the Company agreed to issue an aggregate of 5,000,000 restricted shares of its common stock, consisting of 3,000,000 strategic support shares to SolanAI and 2,000,000 incentive shares to Honwo subject to specified service-related conditions.

On February 24, 2026, the Company issued 1,000,000 restricted common shares to Honwo.

On February 23, 2026, pursuant to the agreement signed on February 21, 2026, the Company issued 3,000,000 common shares to Solan AI Global Ltd for strategic support shares.

On March 10, 2026, the Company entered into a Cooperation Agreement with Australian Fintech Group Pty Ltd. (“AFT Group”) and AEEC International Pty Ltd. (“AEEC”) to establish a strategic partnership in fields of Web3 financial infrastructure, digital payment systems, and digital asset trading platform development.

In connection with this cooperation, the Company, through its subsidiary Crestar Holdings Limited, intends to acquire a 51% equity interest in AEEC, subject to the satisfaction of certain closing conditions. As consideration, the Company agreed to issue an aggregate of 8,000,000 restricted shares of its common stock to AEEC and/or its designated entities upon completion of the transaction.

As of March 31, 2026, the Company had completed a substantial portion of its strategic asset integration and capital structure repositioning, which management believes provides an initial foundation for future platform commercialization and business expansion.

Table of Contents

NOTE 2 – GOING CONCERN

~~The~~As ~~Company’s~~reflected in the financial statements, ~~have~~the ~~been~~Company ~~prepared~~had ~~assuming~~an ~~that~~accumulated itdeficit ~~will~~of $40,815,538 at ~~continue~~March as31, a2026 ~~going~~and ~~concern,~~cash ~~which~~used ~~contemplates~~in ~~continuity~~operations of ~~operations~~$5,483 for ~~realization~~the ofthree ~~assets~~months ended March 31, ~~and~~2026. ~~liquidation~~Management notes, however, that a substantial portion of ~~liabilities~~the inCompany’s reported loss and operating expenses for the ~~normal~~three ~~course~~months ended March 31, 2026 consisted of ~~business~~non-cash items, including stock-based compensation and impairment charges, which did not have a corresponding impact on near-term operating cash flows.

AsThe ~~reflected~~Company's inability ~~the~~to ~~financial~~continue ~~statements,~~as a going concern is contingent upon achieving future profitable operations and securing sufficient financing to meet operational obligations. Management plans to fund operations over the ~~Company~~next ~~had~~twelve anmonths ~~accumulated~~through ~~deficit~~existing ofcash ~~$28~~resources,~~429~~ related party support,~~710 at~~ ~~September~~additional 30debt or equity financing, ~~2025~~and potential capital raises via public or private offerings. Management is actively pursuing these funding and ~~negative~~business ~~operating~~development ~~cash~~initiatives ~~flow~~and ofbelieves ~~$28~~that such efforts,~~209 for~~ ~~nine~~together ~~months~~with ~~ended~~ongoing ~~September~~liability 30management and strategic expansion activities, ~~2025~~may support the Company’s operations and business objectives over the next twelve months. However, there can be no assurance that the Company will ultimately be successful in obtaining sufficient financing or achieving profitable operations.

The Company's ability to continue as a going concern is contingent upon achieving future profitable operations and securing necessary financing to meet operational obligations. Management plans to fund operations over the next twelve months through existing cash reserves, loans from related parties, and potential capital raises via public or private offerings. While management is confident in its ability to obtain financing, generate revenue, meet regulatory requirements, and achieve commercial objectives, there can be no assurance that such funding will be secured or that future operations will be successful.

To improve its financial position, the Company has implemented a comprehensive strategy focused on:

1. Revenue Growth – ~~Expanding~~expanding ~~contracts~~strategic ~~with~~consulting, ~~government~~enterprise technology, and ~~multinational~~infrastructure-related ~~clients while enhancing global~~ service ~~delivery~~opportunities; ~~capabilities~~ 2. Strategic Expansion – ~~Acquiring~~integrating ~~high-potential~~acquired AIbusinesses and ~~Web3~~developing ~~projects~~scalable toWeb3, ~~strengthen~~digital ~~technology~~asset, ~~offerings~~ and ~~attract~~infrastructure ~~top~~platforms; ~~talent~~ 3. Market Development – ~~Increasing~~building ~~participation~~strategic inpartnerships ~~global~~and ~~industry~~expanding ~~events~~commercial ~~and~~relationships ~~executing~~across ~~targeted~~multiple ~~brand-building~~jurisdictions; ~~initiatives~~ 4. Technology Advancement – ~~Systematically~~strengthening ~~filing~~platform ~~patents~~capabilities, tointellectual ~~protect~~property ~~core~~development, ~~innovations~~and commercialization readiness. 5. Capital Structure and ~~build~~Liquidity ~~intellectual~~Management ~~property~~– ~~assets~~pursuing equity and debt financing opportunities, related party support, strategic capital arrangements, and liability restructuring where appropriate.

Management believes these initiatives will ~~drive~~support ~~sustained~~long-term financial improvement and future business expansion. The Company will continue to monitor and report on their operational and financial progress.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying ~~unaudited~~audited ~~interim condensed~~ consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles ~~for interim financial information and~~ in ~~accordance with~~ the ~~instructions~~United toStates ~~Form 10-Q and Article 8~~ of ~~Regulation~~America ~~S-X. In the opinion of management, all adjustments~~ (~~consisting of normal recurring adjustments~~"GAAP") ~~considered~~and ~~necessary~~are ~~for~~presented ain ~~fair~~US ~~presentation have been included~~dollars. ~~Operating~~The ~~results~~Company ~~for~~uses the ~~nine~~accrual ~~months~~basis ~~ended September 30, 2025 are not necessarily indicative~~ of ~~the~~accounting ~~results~~and ~~that~~has ~~may~~a ~~be expected for the year ending~~ December 31, ~~2025. Notes to the unaudited interim financial statements that would substantially duplicate the disclosures contained in the audited financial statements for~~ fiscal year ~~2024 have been omitted~~end. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended December 31, 2024 included in the Company’s Form 10-KT as filed with the Securities and Exchange Commission on March 28, 2025.

Basis of Consolidation

These consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries of Goldfinch Group Holdings Ltd. (including its wholly owned subsidiary Crestar Holding Ltd.), ~~and~~Solan (Shenzhen) Technology Co., Ltd., Xirangsheng (Shenzhen) Health Technology Co., Ltd. , 80% owned Jiansheng (Shenzhen) Technology Co., Ltd. and 51% owned SolanAI Global Ltd. (including its wholly owned subsidiary Yuan Qi (Shenzhen) AI Co., Ltd. and Goldfinch Group Co., Ltd. (including its wholly subsidiary Goldfinch-Chong (Fuzhou) Technology Co., Ltd.. All material intercompany balances and transactions have been eliminated.

					Functional	Acquisition
Entity		% owned			Currency	Date
Transuite. Org. Inc.	Parent				USD
Goldfinch Group Holdings Ltd. (BVI) (Note 1)	Subsidiary		100	%	CNY	11/24/2024
Crestar Holdings Ltd. (Hong Kong)	Subsidiary		100	%	HKD	8/14/2025
Jiansheng (Shenzhen) Technology Co., Ltd.	Subsidiary		80	%	CNY	9/16/2025
Solan (Shenzhen) Technology Co., Ltd.	Subsidiary		100	%	CNY	9/29/2025
Xirangsheng (Shenzhen) Health Technology Co., Ltd.	Subsidiary		100	%	CNY	9/30/2025
Goldfinch Group Co., Ltd. (Hong Kong)	Subsidiary		51	%	HKD	12/31/2025
Goldfinch-Chong (Fuzhouu) Technology Co., Ltd.	Subsidiary		51	%	CNY	12/31/2025
SolanAI Global Ltd. (Hong Kong)	Subsidiary		51	%	HKD	8/25/2025
Yuan Qi (Shenzhen) AI Co., Ltd.	Subsidiary		51	%	CNY	9/3/2025

Note 1: 70% interest acquired on November 24, 2024 and remaining 30% interest acquired on August 20, 2025

Table of Contents

Foreign Currency Translations

The Company’s functional and reporting currency is the U.S. dollar. Goldfinch Group Holdings Ltd.’s, Solan (Shenzhen) Technology Co., Ltd.’s, Xirangsheng (Shenzhen) Health Technology Co., Ltd.’s, ~~SolanAI~~Goldfinch-Chong ~~Global~~(Fuzhouu) Technology Co., Ltd.’s , Yuan Qi (Shenzhen) AI Co., Ltd.’s and ~~Goldfinch~~Jiansheng ~~Group~~(Shenzhen) ~~Holdings~~Technology Co., Ltd.’s functional currency is the Chinese Renminbi (RMB). Crestar Holdings Ltd.’s, Goldfinch Group Co., Ltd.’s and SolanAI Global Ltd.’s functional currency is Hong Kong Dollar (HKD). All transactions initiated in RMB and HKD are translated into U.S. dollars in accordance with ASC 830-30, “Translation of Financial Statements,” as follows:

	1)	Monetary assets and liabilities at the rate of exchange in effect at the balance sheet date.
	2)	Equity at historical rates.
	3)	Revenue and expense items at the average rate of exchange prevailing during the period.

5 Table of Contents

Adjustments arising from such translations are deferred until realization and are included as a separate component of stockholders’ equity as a component of comprehensive income or loss. Therefore, translation adjustments are not included in determining net income (loss) but reported as other comprehensive income (loss). Gains and losses from foreign currency transactions are included in earnings in the period of settlement.

	Nine Months Ended
	Three Months Ended
	September 30,
	March 31,
	2025		2024
	2026		2025
Spot USD:RMB exchange rate		0.~~14044~~14499		-
Average USD:RMB exchange rate		0.~~14044~~14443		-

	Three Months Ended
	March 31,
	2026		2025
Spot USD:HKD exchange rate		0.12756		-
Average USD:HKD exchange rate		0.12799		-

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments

ASC 820, “Fair Value Measurements and Disclosures”, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:

Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

The carrying amounts of financial instruments such as accounts payable and note payable approximate their fair values because of the short maturity of these instruments.

Business Combinations

In accordance with Accounting Standards Codification (“ASC”) 805-10, Business Combinations (“ASC 805-10”), the Company accounts for all business combinations using the acquisition method of accounting. Under this method, assets and liabilities, including any remaining non-controlling interests, are recognized at fair value at the date of acquisition. The excess of the purchase price over the fair value of assets acquired, net of liabilities assumed, and non-controlling interests is recognized as goodwill. Certain adjustments to the assessed fair values of the assets, liabilities, or non-controlling interests made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income. Any cost or equity method interest that the Company holds in the acquired company prior to the acquisition is re-measured to fair value at acquisition with a resulting gain or loss recognized in income for the difference between fair value and the existing book value. Results of operations of the acquired entity are included in the Company’s results from the date of the acquisition onward and include amortization expense arising from acquired tangible and intangible assets.

610 Table of Contents

Cash and Cash Equivalents

For the purposes of the statement of cash flows, the Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, the Company had bank ~~balance~~balances of $144,~~030~~545 and $03,705, respectively.

Funds held in trust comprise funds held in a trust account by the Company’s legal counsel. As of September 30, 2025 and December 31, 2024, the Company had $0 and $16,103 in funds held in trust, which are also considered cash equivalent.

Accounts Receivable

Accounts receivables are recorded in accordance with ASC 310, “Receivables,” at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company does not currently have any amount recorded as an allowance for doubtful accounts. Based on the management’s estimate and based on all accounts being current, the Company has not ~~deemed~~determined it necessary to establish a reserve for doubtful accounts at this time.

As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, accounts receivable was $15120,~~000~~781 and $019,299, respectively. The Company assessed that the recognition for current expected credit losses is not required as of March 31, 2026.

Prepaid Expenses

Prepaid expenses are amounts paid to secure the use of assets or the receipt of services at a future date or continuously over one or more future periods. When the prepaid expenses are eventually consumed, they are charged to expense.

As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there were $1638,~~062~~ 710 and $018,757 in ~~other receivable and prepayment~~prepaids, respectively.

Goodwill

The Company accounts for goodwill in accordance with ASC 350 “Intangibles-Goodwill and Other.”

ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. In addition, ASC 350 requires that goodwill be tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests when circumstances indicate that the recoverability of the carrying amount of goodwill may be in doubt. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, and determining the fair value. Significant judgments required to estimate the fair value of reporting units include estimating future cash flows, determining appropriate discount rates and other assumptions. Changes in these estimates and assumptions or the occurrence of one or more confirming events in future periods could cause the actual results or outcomes to materially differ from such estimates and could also affect the determination of fair value and/or goodwill impairment at future reporting dates.

As of ~~September~~December 3031, 2025, goodwill of $12,~~501~~500,~~149~~399 was generated through the acquisition of 51% equity interest in SolanAI Global Ltd., $1,701,719 was generated through the acquisition of 100% equity interest in Xirangsheng (Shenzhen) Health Technology Co., Ltd. and $483,153 was generated through the acquisition of 51% interest in Goldfinch Group Co., Ltd. (Hong Kong) and its wholly owned subsidiary Goldfinch-Chong (Fuzhouu) Technology Co., Ltd. (Note 9)

Based on the Company’s analysis of goodwill as of December 31, 2025, the fair value of the reporting unit based on estimated future cash flow falls below its carrying value and shows negative recoverability, goodwill was fully impaired and impairment loss on goodwill of $14,685,271 was incurred.

Intangible Asset

The Company accounts for its intangible assets in accordance with ASC Subtopic 350-40, Internal-Use Software-Computer Software Developed or Obtained for Internal Use, and ASC Subtopic 360-10, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-40 requires assets to be recorded at the cost to develop the asset and requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life.

We11 ~~capitalized~~Table ~~website development and databases costs~~ of $64,500, which is being amortized over a 5-year life. During the nine months ended September 30, 2025 and September 30, 2024, we recognized $9,684 and $9,842 worth of amortization expense, respectively. As of September 30, 2025 and December 31, 2024, the website development and database cost were $33,653 and $40,531, net of accumulated amortization of $33,653 and $23,969.Contents

OnDuring ~~September~~fiscal ~~30,~~year ~~2025~~2022 to 2023, the Company ~~acquired~~capitalized AIwebsite ~~Social~~development ~~Agent~~and ~~for~~databases ~~Traditional~~costs ~~Chinese Medicine~~ of $2464,~~577~~500,~~000~~ ~~from~~which ~~the~~were ~~acquisition~~being amortized over a 5-year life. As of ~~Xirangsheng~~December ~~(Shenzhen)~~31, ~~Health~~2025, ~~Technology~~the Cointangible assets were fully impaired and written off. During the three months ended March 31, ~~Ltd.~~2026 and 2025, we recognized $0 and $3,228 worth of amortization expense, respectively.

As of September 30, 2025 and December 31, 2024, the total intangible assets were $24,607,847 and $40,531, net of accumulated amortization of $33,653 and $23,969.

Net book value as of December 31, 2023	$	53,601
Additions		-
Disposal		-
Amortization		(13,070	)
Net book value as of December 31, 2024		40,531
Additions		-
Disposal		-
Amortization		(12,912	)
Impairment		(27,619	)
Net book value as of December 31, 2025	$	-

Long lived Assets

Long-lived assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the undiscounted future cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value.

7Property ~~Table~~and ~~of Contents~~Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method. The depreciation methods are designed to depreciate the cost of the assets over their estimated useful lives, in years

As of March 31, 2026 and December 31, 2025, the Company has e-charging equipment of $41,724 and $17,160, respectively, amortized over five years of useful life. During the three months ended March 31, 2026 and March 31, 2025, depreciation expense was $2,196 and $0, respectively.

Balance as of December 31, 2024	$	-
Addition		17,160
Disposal		-
Depreciation		-
Balance as of December 31, 2025	$	17,160
Addition		26,521
Disposal		-
Depreciation		(2,196	)
Foreign Exchange Adjustment		239
Balance as of March 31, 2026	$	41,724

Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation in respect of which the likelihood of outflow of resources is remote, no provision or disclosure is made. Contingent assets are not recognized in the financial statements. A contingent asset is disclosed where an inflow of economic benefits is probable. Contingent assets are assessed continually and, if it is virtually certain that an inflow of economic benefits will arise, the asset and related income are recognized in the period in which the change occurs.

Table of Contents

Related Party Balances and Transactions

The Company follows FASB ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transaction.

Convertible Financial Instruments

The Company account for our convertible financial instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU2020-06 removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature (“CCF”) and (2) convertible instruments with a beneficial conversion feature (“BCF”). With the adoption of ASU2020-06, entities will not separately present in equity an embedded beneficial conversion feature from the convertible debts.

Expected credit losses

The Company estimates and records a provision for its expected credit losses related to its financial instruments, including its trade receivables. Management considers historical collection rates, the current financial status of the Company’s customers, macroeconomic factors, and other industry-specific factors when evaluating current expected credit losses. However, because of the short time to the expected receipt of accounts receivable, management believes that the carrying value, net of expected losses, approximates fair value and therefore, relies more on historical and current analysis of such financial instruments, including its trade receivables.

Credit loss rate is determined by historical collection based on aging schedule, adjusted for current conditions using reasonable and supportable forecasts. Based on the aging categorization and the adjusted loss rate per category, an allowance for credit losses is calculated by multiplying the adjusted loss rate with the amortized cost in the respective age category. The amendments in ASU 2025‑05 introduce a practical expedient for all qualifying assets that allows the Company to assume that current conditions at the balance-sheet date remain unchanged for the remaining life of an asset when estimating credit losses on current accounts receivable and current contract assets. The Company electing this expedient will therefore adjust historical loss experience only to reflect current conditions, without the need to incorporate forward‑looking forecasts.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, “Revenue Recognition” following the five steps procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when the entity satisfies a performance obligation

~~The~~During ~~Company’s~~the ~~revenue~~three ~~derives~~months ~~from~~ended ~~its~~March ~~AI-Driven~~31, ~~Ecosystem~~2026, ~~Product~~the ~~Planning consulting service which enhances client~~Company’s ~~operational~~revenue ~~capabilities,~~was ~~market~~primarily ~~reach,~~derived ~~and~~from ~~technological~~our ~~infrastructure in the live~~ e-~~commerce~~bike ~~sector.~~charging ~~During~~management ~~the~~solutions ~~nine~~and ~~months~~on-line ~~ended~~medical ~~September 30, 2025, the Company recognized service revenue of $115,000~~education.

The transaction price is determined based on the consideration specified in the contract. Revenue is recognized when control of the goods or services deliverables defined in each contract are transferred to the customer. For online education solutions, revenue is recognized at a point in time or over time, depending on the nature of the arrangement and the transfer of control.

The Company’s payment terms vary by contract but generally require payment within a specified period following invoicing. In certain arrangements, the Company may receive advance payments, which are recorded as deferred revenue and recognized as revenue when the related performance obligations are satisfied.

During the three months ended March 31, 2026, and 2025 the Company’s 51% owned subsidiary Goldfinch-Chong (Fuzhou) Technology Co., Ltd. recognized e-bike charging revenue of $120,640 and $0, respectively.

During the three months ended March 31, 2026, and 2025 the Company’s wholly owned subsidiary Solan (Shenzhen) Technology Co., Ltd. recognized online medical education revenue of $1,144 and $0, respectively.

During the three months ended March 31, 2026 and 2025, the Company recognized total revenue of $121,784 and $0, respectively.

Table of Contents

Share-Based Compensation

The Company accounts for share-based compensation under the fair value method in accordance with ASC 718, “Compensation – Stock Compensation,” which requires all such compensation to employees and non-employees to be calculated based on its fair value of the equity instrument at the grant date and recognized in the earnings over the requisite service or vesting period.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025 and 2024~~2026, the Company ~~recorded~~granted restricted common stock to consultants for services at aggregate valuation of $27155,~~938,890~~000 and ~~$0 in~~cancelled restricted stock~~-based~~ ~~compensation,~~previously ~~respectively~~issued to consultants at aggregate valuation of $522,324. ~~The~~During ~~stock-based~~the ~~compensation~~three ~~incurred~~months ~~from~~ended March 31, 2025, the Company granted restricted common stock ~~awarded~~ to consultants ~~was~~for ~~reported~~services ~~under~~for ~~professional~~services ~~fees~~at inaggregate ~~the~~valuation ~~statements~~ of ~~operation~~$408,850.

8Pursuant ~~Table~~to a cooperation agreement signed with Honwo Technology Holding Ltd, the Company issued 1,000,000 shares of ~~Contents~~restricted common stock to Honwo as incentive shares upon the execution date of the agreement valued at $190,000, with another 500,000 shares and 500,000 shares to be issued 6 months and 12 months from the execution date of the agreement, respectively. The Company has accrued stock-based compensation for February 21 to March 31, 2026 outstanding portion of incentive shares at $19,996 recorded under stock payable.

During the three months ended March 31, 2026, the Company recorded stock-based compensation of $3,474,935 for the Q1 2026 vested portion of the unvested portion of restricted shares previously recorded under deferred compensation during the year ended December 31, 2025.

During the three months ended March 31, 2026 and March 31, 2025, the Company recorded total stock-based compensation of $3,317,607 and $408,850, respectively.

Net Income (Loss) Per Share

Basic net income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed similar to basic net income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted net income per share assumes the conversion, exercise or issuance of all common stock instruments, such as convertible notes, unless the effect is to reduce a loss or increase earnings per share.

~~For~~Income ~~the nine months ended September 30, 2025 and 2024, the following convertible note was excluded from the computation of diluted net loss per shares as the result of the computation was anti-dilutive:~~Taxes

	September 30,		September 30,
	2025		2024
	(Shares)		(Shares)
Convertible Notes		-		5,117,333

The Company accounts for income taxes using the asset and liability method prescribed by ASC 740 “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the years in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

The Company also conducts major business in China and Hong Kong and is subject to tax in these jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

The Company adopted the ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which modifies the rules on income tax disclosures to require disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid.

Recent Accounting Pronouncements

In ~~December~~November ~~2023~~2024, the FASB issued ASU ~~No. 2023~~2024-0903, Income ~~Taxes~~Statement—Reporting ~~(Topic~~Comprehensive ~~740) - Improvements to~~ Income—Expense ~~Tax~~Disaggregation Disclosures (~~"ASU~~Subtopic ~~2023~~220-~~09"~~40), which isrequires ~~intended~~enhanced todisclosures ~~enhance~~of ~~the~~certain ~~transparency~~income ~~and~~statement ~~decision~~expenses. ~~usefulness~~In ofJanuary ~~income~~2025, ~~tax~~the ~~disclosures.~~FASB ~~The~~issued ~~amendments in~~ ASU ~~2023~~2025-0901 ~~provide for enhanced income tax information primarily through changes~~ to clarify the ~~rate~~effective ~~reconciliation~~date ~~and~~of ~~income~~ASU ~~taxes paid information~~2024-03. ~~ASU~~The ~~2023-09~~standard is effective for ~~the~~fiscal ~~Company~~years ~~prospectively to all annual periods~~ beginning after December 15, ~~2024.~~2026, ~~Early~~and ~~adoption~~interim isperiods ~~permitted.~~within ~~The~~fiscal ~~Company~~years ~~has~~beginning ~~not~~after ~~yet~~December ~~adopted~~15, ~~this~~2027. ~~standard~~Early ~~and~~adoption is ~~currently~~permitted, ~~evaluating~~either ~~the~~prospectively ~~impact~~or ~~this update will have on its financial statements and disclosures~~ retrospectively ~~upon the future adoption~~.

In ~~July~~December 2025, the FASB issued ~~Accounting~~ASU ~~Standards Update~~ No.2025-~~05,~~11- ~~Financial~~“Interim ~~Instruments~~Reporting” ~~– Credit Losses~~ (~~Topic 326~~Topic270): ~~Measurement of Credit Losses for Accounts Receivable and Contract Assets (~~“~~ASU 2025~~Narrow-05Scope Improvements”). ~~ASU~~which ~~2025-05~~is ~~provides~~designed ato ~~practical~~improve ~~expedient~~the ~~that~~navigability ~~all~~of ~~entities~~interim ~~can~~reporting ~~use~~guidance ~~when estimating expected credit losses for current accounts receivable~~ and ~~current~~clarify ~~contract~~its ~~assets~~applicability ~~arising~~without ~~from~~fundamentally ~~transactions~~changing ~~accounted~~the ~~for~~nature ~~under~~of ~~ASC~~interim ~~606, Revenue from Contracts with Customers~~reporting. ~~Under~~In ~~this~~introduces ~~practical~~a ~~expedient,~~principle anrequiring ~~entity~~entities ~~is allowed~~ to ~~assume~~disclose ~~that~~events ~~the~~or ~~current~~changes ~~conditions~~since itthe ~~has~~last ~~applied~~annual inreporting ~~determining~~period ~~credit~~that ~~loss~~have ~~allowances~~a ~~for~~material ~~current~~impact ~~accounts~~on ~~receivable and current contract assets remain unchanged for~~ the ~~remaining life of those assets~~entity. ~~ASU~~The ~~2025-05~~new guidance is effective for ~~fiscal~~annual ~~years~~reporting periods beginning ~~after~~ December 15, ~~2025, and interim reporting periods in those years~~2027. ~~Entities~~Early ~~that~~adoption ~~elect~~is ~~the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively~~permitted. We are currently evaluating the ~~potential~~ impact ofthis ~~adopting~~update ~~ASU~~will ~~2025-05~~have on our consolidated financial statements and disclosures.

Table of Contents

We have evaluated all other recently issued, but not yet effective, accounting pronouncements and do not believe that these accounting pronouncements will have any material impact on our consolidated financial statements or disclosures upon adoption.

Recent Adopted Accounting Standards

In ~~November~~July ~~2023~~2025, the FASB issued ~~ASU~~Accounting ~~No.~~Standards ~~2023~~Update 2025-0705, ~~Segment~~“Financial ~~Reporting~~Instruments – Credit Losses” (Topic ~~280~~326): -“Measurement ~~Improvements~~of toCredit ~~Reportable~~Losses ~~Segment~~for ~~Disclosures~~Accounts Receivable and Contract Assets” ("“ASU ~~2023~~2025-~~07"~~05”),. ~~which~~ASU ~~require~~2025-05 ~~public~~provides ~~companies~~a ~~disclose~~practical ~~significant~~expedient ~~segment~~that ~~expenses~~all ~~and~~entities ~~other~~can ~~segment~~use ~~items~~when onestimating anexpected ~~annual~~credit ~~and~~losses ~~interim~~for ~~basis~~current accounts receivable and tocurrent ~~provide~~contract inassets ~~interim~~arising ~~periods~~from ~~all~~transactions ~~disclosures~~accounted ~~about~~for aunder ~~reportable~~ASC ~~segment's~~606, ~~profit~~Revenue orfrom ~~loss~~Contracts ~~and~~with ~~assets~~Customers. Under this practical expedient, an entity is allowed to assume that ~~are~~the ~~currently~~current ~~required~~conditions ~~annually.~~it ~~The~~has ~~guidance~~applied isin ~~effective~~determining credit loss allowances for ~~public~~current ~~entities~~accounts receivable and current contract assets remain unchanged for ~~fiscal~~the ~~years~~remaining ~~beginning~~life ~~after~~of ~~December~~those ~~15,~~assets. ~~2023,~~ASU ~~and~~2025-05 ~~interim~~is ~~periods~~effective ~~within~~for fiscal years beginning after December 15, ~~2024.~~2025, ~~Early~~and ~~adoption~~interim isreporting ~~permitted~~periods in those years. ~~The~~Entities ~~guidance~~that iselect ~~applied~~the ~~retrospectively~~practical toexpedient ~~all~~and, ~~periods~~if ~~presented~~applicable, inmake the ~~financial~~accounting ~~statements,~~policy ~~unless~~election itare isrequired ~~impracticable~~to apply the amendments prospectively. The adoption of ASU ~~2023~~2025-0705 has not had a material effect on the Company’s statements and disclosures.

NOTE 4 – DEFERRED SHARE ISSUANCE COST

On January 25, 2025, the Company entered into an Equity Purchase Agreement with Williamsburg Venture Holdings, LLC, a Nevada limited liability company, pursuant to which the Investor agreed to invest up to $5,000,000 over a 24-month period. During the term, the Company shall be entitled to put to Williamsburg, and Williamsburg shall be obligated to purchase, such number of shares of the Company’s common stock and at such price as are determined in accordance with the Equity Purchase Agreement. The per share purchase price for the Williamsburg Put Shares will be equal to 90% the lowest traded price of the Common Stock on the principal market during the five (5) consecutive trading days immediately preceding the date which Williamsburg received the Williamsburg Put Shares as DWAC Shares in its brokerage account (as reported by Bloomberg Finance L.P., or other reputable source).

On March 6, 2025, the Company amended the Equity Purchase Agreement with Williamsburg Venture Holdings, LLC to increase the maximum commitment amount from $5 million to $10 million. The Company shall issue up to 270,000 commitment shares to Williamsburg. These shares will be earned and issued in tranches according to the following milestones:

	·	50% of the commitment shares (135,000 shares) issued on the execution date

	·	50% of the commitment shares (135,000 shares) will be issued once the investor reaches 50% of the maximum commitment amount.

During the ~~nine~~year ~~months~~ ended ~~September~~December 3031, 2025, upon the execution of the Equity Purchase Agreement, the Company issued 135,000 shares of common stock valued at $249,750 as commitment shares to the investor. During the ~~nine~~year ~~months~~ ended ~~September~~December 3031, 2025, the Company also made a $5,000 payment to the investor as documentation fee for the ~~reparation~~preparation of the Equity Purchase Agreement and Registration Rights Agreement.

~~As of September 30, 2025, the deferred share issuance cost aggregated to $254,750~~ . ~~These costs are deferred and will be deducted from the proceeds from future stock issuance to the investor under the Equity Purchase Agreement.~~

10 As ~~Table~~ of ~~Contents~~March 31, 2026 and December 31, 2025, the deferred share issuance cost aggregated to $254,750. These costs are deferred and will be deducted from the proceeds from future stock issuance to the investor under the Equity Purchase Agreement.

As of March 31, 2026 and December 31, 2025, no investment funds had been received from Williamsburg Venture Holdings, LLC under the Equity Purchase Agreement. The commitment shares issued represent consideration for entering into the agreement and related services, and the deferred share issuance costs will be offset against proceeds from future stock issuances, if any, under the Equity Purchase Agreement.

NOTE 5 – LOAN PAYABLE

On September 15, 2024, the Company entered into a loan agreement with a non-affiliate party at $128,401 to support operating expense of the Company. The loan has a maturity date of September 15, 2026 and interest rate at 8% per annum. ~~During~~On December 3, 2025, the ~~nine~~Company ~~months~~entered ~~ended~~into ~~September~~a ~~30,~~loan ~~2025,~~settlement ~~repayment~~agreement through the issuance of ~~$25~~2,~~000~~140,016 ~~was~~common ~~made~~shares. As of ~~September~~December 3031, 2025, 2,140,016 shares remained outstanding and were recorded as stock payable. As of March 31, 2026 and December 31, ~~2024~~2025, the loan payable was $~~103,401 and $128,401, respectively~~0.

On November 25, 2024, Goldfinch Group Holdings Ltd. entered into a loan agreement with a non-affiliate party at $20,~~041~~533 (CNY145,172) to support legal set-up cost of the Company. The loan has a maturity date of November 25, 2026 and interest rate at 10% per annum. On December 3, 2025, the Company entered into a loan settlement agreement through the issuance of 342,216 common shares. As of December 31, 2025, 342,216 shares remained outstanding and were recorded as stock payable. As of March 31, 2026 and December 31, 2025, the loan payable was $0.

On15 ~~March~~Table ~~31, 2025, the Company entered into a loan agreement with a non-affiliate party at $41,820 to support operating expense~~ of ~~the Company. The loan has a maturity date of March 31, 2027 and interest rate at 8% per annum.~~ Contents

On ~~June~~March 3031, ~~2025~~2026, the Company entered into a loan agreement with ~~the~~a ~~same~~ non-affiliate party at $640,~~800~~692 to support operating expense of the Company during the three months ended March 31, 2026. The loan has a maturity date of ~~June~~ 30March 31, ~~2027~~2028 and interest rate at 8% per annum. As of March 31, 2026, the loan payable was $40,692.

AsInterest ofexpense ~~September~~for ~~30,~~the ~~2025,~~three ~~the~~months ~~loan~~ended ~~payable~~March to31, ~~the~~2026 ~~non-affiliate~~and ~~was~~2025 were $480 and $3,~~620~~069.

OnAs ~~March 31, 2025, the Company entered into a loan agreement with a non-affiliate party at $5,000 to support operating expense~~ of ~~the Company. The loan has a maturity date of~~ March 31, ~~2027~~2026 and ~~interest rate at 8% per annum. During the nine months ended September 30, 2025, repayment of $5,000 was made. As of September 30, 2025 and~~ December 31, ~~2024~~2025, the loan payable was $040,692 and $50,~~000,~~ respectively.

~~During~~NOTE 6 ~~the~~– ~~nine~~RELATED ~~months~~PARTY ~~ending~~TRANSACTIONS ~~September~~AND ~~30, 2025 and 2024, interest expense was $11,224 and $3,987, respectively. As of September 30, 2025 and December 31, 2024, the accrued interest payable was $14,477 and $3,253, respectively.~~ BALANCES

As1) Nature of ~~September~~relationships ~~30,~~with ~~2025~~related ~~and December 31, 2024, the loan payable was $172,062 and $148,442, respectively.~~ parties

~~NOTE 6~~The –table ~~CONVERTIBLE~~below ~~NOTE~~sets ~~PAYABLE~~forth the major related parties and their relationships with the Company, with which the Company entered into transactions for the three months ended March 31, 2026 and 2025 and recorded balances as of March 31, 2026 and December 31, 2025, respectively.

On November 8, 2023, the Company issued a convertible promissory note to a non-affiliate at $153,520. The convertible note is non-interest bearing, has a maturity date of November 8, 2024 and is convertible at $0.03 per share of the Company’s common stock. On August 21, 2024, the non-affiliate transferred and assigned the convertible note to another non-affiliate.

Name of Related Party		Relationship to the Company
Mengqing Fan		Director of Transuite.Org. Inc.
Xiaohuan Song		Director of Goldfinch Group Holdings Ltd. and Goldfinch Group Co., Ltd. (Hong Kong)
Hailiang Li		Director of Xirangsheng (Shenzhen) Health Technology Co., Ltd. and Solan (Shenzhen) Technology Co., Ltd.
Zeng Lianghui		Director of Goldfinch-Chong (Fuzhou) Technology Co., Ltd.
Qianglong Zeng		Former Director of Transuite.Org. Inc. resigned on February 12, 2026

On2) ~~March~~Balances ~~06,~~with ~~2025,~~related ~~the convertible note was fully converted into 5,117,333 shares of common stock.~~parties

As of September 30, 2025 and December 31, 2024, convertible note payable was $0 and $153,520, respectively.

	As of		As of
	March 31, 2026		December 31, 2025
Amount due from related party

Non-trade
Amount due from Mengqing Fan	$	19,801	$	8,901
	$	19,801	$	8,901
Amount due to related parties

Non-trade
Amount due to Xiaohuan Song	$	1,786	$	1,785
Amount due to Zeng Lianghui		1,450		1,430
Amount due to Hailiang Li		12,102		8,467
	$	15,338	$	11,682

113) ~~Table~~Transactions ofwith ~~Contents~~related parties

NOTE 7 – RELATED PARTY TRANSACTIONS AND BALANCES

	For the			For the
	three months ended			three months ended
	March 31, 2026			March 31, 2025

Advancement from Mengqing Fan for Transuite.Org. Inc. operation expenses	$	-		$	9,606
Repayment to Mengqing Fan for her advancement to Transuite Org.	$	(10,900	)	$	-
Advancement from Hailiang Li for Xirangsheng Health Technology operation expenses	$	360		$	-
Advancement from Hailiang Li for Solan (Shenzhen) Technology Co., Ltd.operation expenses	$	3,275		$	-
Stock-based compensation expense incurred from issuance of common stock to Qianglong Zeng for services	$	11,096		$	-

~~Loan~~16 ~~payable~~Table –of ~~related parties~~Contents

Effective June 15, 2018, the Company entered a loan agreement with its former CEO. The lender agreed to lend a total of $50,000 payable in applicable instalments over the Term of the loan. The CEO agreed to an interest rate of 0% and a term of 5 years. Effective October 6, 2022, the CEO agreed to increase maximum amount of the loan to $100,000 and extend the term to NOTE 7 years or until June 15, 2025. During the three months ended March 31, 2024, the former director for the Company who resigned on August 28, 2024 upon change of control, made payments to vendors on behalf of the Company of $27,491. During the six months ended June 30, 2024, imputed interest of $3,321 was incurred and recorded to additional paid-in capital. Upon his resignation on August 28, 2024, the loan to the former director of $104,696 was forgiven and recorded to additional paid in capital. The amount due under to loan was $0 as of September 30, 2025 and December 31, 2024, respectively.EQUITY

~~During~~Preferred the nine months ending September 30, 2025 and 2024, the current director of the Company, who was appointed on October 28, 2024, made payment to vendors of $23,045 and $0 on behalf of the Company, respectively. During the nine months ended September 30, 2025, she was repaid at $24,000. As of September 30, 2025 and December 31, 2024, the amount due to the director of the Company was $1,199 and $2,154, respectively.Shares

~~During~~On ~~the~~April ~~nine months ended September 30~~14, ~~2025~~2026, the ~~director~~Company offiled ~~Goldfinch~~Amended ~~Group Holdings Ltd. made payment on incorporation~~ and ~~registration~~Restated ~~cost~~Articles ~~on behalf~~ of ~~its~~Incorporation ~~wholly~~establishing ~~subsidiary Crestar Holding Ltd. of $2~~100,~~013.~~000,000 Asshares of ~~September~~preferred 30stock, ~~2025,~~par ~~the~~value ~~amount~~$0.001 ~~due~~per toshare ~~the~~in ~~director~~one ofor ~~the~~more ~~Goldfinich was $2,013~~ series.

AsCommon ~~of September 30, 2025 and December 31, 2024, the amount due to the related parties was $13,212 and $2,154, respectively.~~Shares

~~NOTE 8~~Three -Months ~~EQUITY~~Ended March 31, 2026

~~The~~On April 14, 2026, the Company ~~has~~filed Amended and Restated Articles of Incorporation increasing the number of authorized common shares from 75,000,000, to 1,000,000,000 $0.001 par value shares of common stock ~~authorized~~.

~~During~~On ~~the~~January ~~nine months ended September 30~~2, ~~2025~~2026, the Company issued an2,140,016 ~~aggregate~~common shares for the settlement of ~~15,570,000~~loan ~~shares~~payable of ~~common~~$128,401 ~~stock~~in pursuant to ~~consultants~~the ~~for~~settlement ~~service~~agreement ~~rendered~~entered ~~valued~~on atDecember ~~$27~~3,~~888,890~~ 2025. (Note 5)

~~During~~On ~~the~~January ~~nine months ended September 30~~16, ~~2025~~2026, ~~upon~~ the ~~execution~~Company ofissued ~~the~~666,666 ~~Equity~~common ~~Purchase~~shares ~~Agreement~~for ~~with Williamburg Venture Holding, LLC,~~ the ~~Company~~settlement ~~issued~~of ana ~~aggregate~~trade payable of ~~135~~$40,000 ~~shares~~in ofpursuant ~~common~~to ~~stock~~the ~~valued~~settlement atagreement ~~$249,750~~entered ason ~~commitment~~December ~~shares~~3, 2025. (Note 5)

~~During~~On ~~the~~March ~~nine~~31 ~~months~~2026, ~~ended~~the ~~September~~Company ~~30,~~issued ~~2025~~342,216 acommon ~~convertible~~shares ~~note~~for the settlement of loan payable of $~~153~~20,~~250~~533 ~~was~~in ~~fully~~pursuant ~~converted~~ to ~~5,117,333~~the ~~shares~~settlement ofagreement ~~common~~entered ~~stock~~on December 3, 2025. (Note 5)

OnFrom ~~August~~January ~~20,~~to ~~2025~~February 2026, ~~the Company issued~~ 3,~~000~~500,000 common shares were issued as partial consideration for the acquisition of ~~common~~51% ~~stock~~equity atinterest $2in Goldfinch Group Co.00 ~~per~~Ltd. (Hong Kong) in pursuant to share ~~with~~exchange aagreement ~~fair~~entered ~~value~~on ofDecember $631,~~000,000~~ to2025. ~~acquire~~The ~~the~~ remaining ~~30%~~consideration ~~equity~~of ~~interest~~1,500,000 incommon ~~Goldfinch~~shares ~~Group~~will ~~Holdings~~be ~~Ltd~~issued within year 2026.

OnPursuant ~~August~~to ~~25,~~a ~~2025,~~cooperation ~~the~~agreement ~~Company~~entered ~~issued~~with ~~10,000,000~~Honwo ~~shares~~Technology ofHolding ~~common~~Limited ~~stock~~(“Honwo”) atto ~~$1.25~~establish ~~per~~a ~~share~~strategic ~~with~~collaboration aframework ~~fair~~in ~~value~~Web3 oftechnology ~~$12~~and related business development on February 21,~~500~~ 2026, the Company issued 1,000,000 asrestricted ~~initial~~common ~~consideration~~shares ~~for~~to ~~the~~Honwo ~~acquisition~~as ofincentive ~~51%~~shares ~~equity~~valued ~~interest~~at in$190,000 ~~SolanAI~~on ~~Global~~February ~~Ltd~~24, 2026.

On ~~September~~February 3023, ~~2025~~2026, ~~the~~pursuant ~~Company~~to ~~issued~~the ~~10,000,000~~agreement ~~restricted~~signed ~~shares~~on ofFebruary ~~common~~21, ~~stock~~2026, atthe ~~$0.17~~Company ~~per~~issued ~~share with a fair value of $1~~3,~~700~~000,000 ascommon ~~initial~~shares ~~consideration~~to ~~for~~Solan ~~the~~AI ~~acquisition~~Global ofLtd ~~100%~~for ~~equity~~strategic ~~interest~~support inshares ~~Xirangsheng~~valued ~~(Shenzhen)~~at ~~Health Technology Co.~~$600, ~~Ltd~~000. OnThe ~~September~~shares ~~30,~~were ~~2025,~~recorded ~~the~~as ~~Company~~treasury ~~completed~~stock in the ~~acquisition~~Balance ~~of 100% of XRS~~ Sheet.

AsFrom ofJanuary ~~September~~to ~~30,~~February ~~2025 and December 31~~2026, ~~2024,~~ the Company issued ~~and~~an ~~outstanding~~aggregate of 1,550,000 common ~~stock~~shares ~~was~~valued 47at $155,~~869,093~~000 ~~and~~to ~~4,046,760~~consultants ~~shares,~~for ~~respectively~~service rendered.

Pursuant to termination agreements, from January to March 2026, the Company cancelled an aggregate of 1,670,000 common shares previously issued to consultants for service valued at $522,324.

Three Months Ended March 31, 2025

On February 25, 2025, the Company issued an aggregate of 221,000 shares of common stock to four consultants for service rendered valued at $408,850.

During the three months ended March 31, 2025, upon the execution of the Equity Purchase Agreement with Williamburg Venture Holding, LLC, the Company issued an aggregate of 135,000 shares of common stock valued at $249,750 as commitment shares.

On March 06, 2025, a convertible note of $153,250 was fully converted to 5,117,333 shares of common stock.

As of March 31, 2026 and December 31, 2025, the issued and outstanding common stock was 71,783,325 and 61,254,427 shares, respectively.

Table of Contents

Incentive Stock Option Plan

On October 14, 2025, the Company obtained written consent by the holders of the majority of the voting power of the Company's capital stock approving the adoption of the Company’s 2025 Stock Incentive Plan (the “Plan”). The Plan allows the Board of Directors of the Company to grant incentive stock options, nonqualified stock options and restricted stock awards to officers, directors, employees and consultants of the Company. At the time of consent, there were 7,000,000 shares of common stock of the Company reserved for issuance under the Plan. As of March 31, 2026, 5,000,000 shares had been granted under the Plan, and 2,000,000 shares remained available for future grants.

Stock Payable

On ~~August~~December 1231, 2025, the Company ~~accrued~~entered ~~stock~~into ~~payable~~a share exchange agreement for the acquisition of ~~$50~~51% of Goldfinch Group Co. Ltd. (Hong Kong),~~000~~ ~~for~~which 25holds 100% of Goldfinch-Chong (Fuzhou) Technology Co., Ltd., through the issuance of 5,000,000 restricted common ~~stock~~shares. During ~~payable~~the ~~upon~~three 6 months ~~from~~ended ~~effective~~March ~~date~~31, ~~February~~2026, 123,500,000 ~~2025~~shares ~~per~~were ~~consulting agreement~~issued. ~~(Note~~As ~~10)~~of March 31, 2026, 1,500,000 shares remained outstanding and were recorded as stock payable.

Pursuant to a cooperation agreement signed with Honwo Technology Holding Ltd, the Company issued 1,000,000 shares of restricted common stock to Honwo as incentive shares upon the execution date of the agreement valued at $190,000, with another 500,000 shares and 500,000 shares to be issued 6 months and 12 ~~Table~~months from the execution date of ~~Contents~~the agreement, respectively. The Company has accrued stock-based compensation for February 21 to March 31, 2026 outstanding portion of incentive shares at $19,996 recorded under stock payable.

~~NOTE~~As of March 31, 2026 and December 31, 2025, the stock payable was $169,997 9and –$688,934 ~~ACQUISITION~~for outstanding 1,605,251 and 8,148,898 common shares, respectively.

~~Xirangsheng~~NOTE ~~(Shenzhen)~~8 ~~Health~~– ~~Technology~~CONCENTRATION ~~Co.,~~OF ~~Ltd.~~RISK

OnMajor September 30, 2025, the Company entered into a share exchange agreement with Crestar Holdings Ltd., wholly owned subsidiary of Goldfinch Group Holdings Ltd., and Hailiang Li for the acquisition of 100% equity interest in Xirangsheng (Shenzhen) Health Technology Co., Ltd. (“XRS”), an innovative enterprise based on the combination of AI Social Agent and Traditional Chinese Medicine, through the issuance of 10,000,000 restricted common shares at $0.17 per share with a fair value $1,700,000 as initial consideration. The Company may issue additional shares within 60 days after receipt of the independent valuation of XRS upon terms agreed on the Agreement, subject to Board approval and compliance with applicable securities laws. Customers

~~The~~For ~~acquisition~~the ~~was~~three ~~closed~~months onended ~~September~~March 3031, ~~2025.~~2026, ~~XRS~~the ~~has~~Company ~~been~~generated ~~included~~total inrevenue ~~our~~of ~~consolidated~~$121,784 ~~balance~~of ~~sheets~~which ~~since~~three customers accounted for 55.5%, 23.6% and 20.9% of the ~~acquisition~~Company’s ~~date~~total revenue. For the three months ended March 31, 2025, the company generated $0 in revenue.

~~The~~As ~~following~~of ~~table~~March ~~summarizes~~31, ~~the~~2026 ~~preliminary~~three ~~identifiable~~customers ~~assets~~represented ~~acquired~~62.7%, 19.7% and ~~liabilities~~17.5% ~~assumed~~of ~~upon~~the ~~acquisition~~outstanding accounts receivable balance $120,781. As of ~~XRS~~December ~~and~~31, 2025, one customer represented 100% of the ~~calculation~~outstanding accounts receivable balance of ~~contingent~~$19,299. ~~liability:~~

Total purchase price	$	1,700,000
Bank		1,458
Prepaid Expense		6,644
Other Receivable		2,743
Intangible Assets		24,577,000
Total identifiable assets		24,587,845
Other Payable		(12,564	)
Total identifiable liabilities		(12,564	)
Net assets		24,575,281
Contingent Liability	$	(22,875,281	)

NOTE 9 - INCOME TAX

The Company, onprovides ~~consolidation~~for ofincome ~~the~~taxes ~~acquired~~under ~~entity~~ASC 740, ~~has~~“Income ~~included~~Taxes.” Under the ~~value~~asset and liability method of ~~$24~~ASC 740,~~575,281~~ ~~and~~deferred atax ~~contingent~~assets ~~liability~~and ofliabilities ~~$22,875,281. The~~are ~~contingent~~recorded ~~liability~~based ~~valuation~~on isthe ~~pending~~differences between the ~~independent~~financial ~~valuation~~statement ~~report~~and tax basis of ~~the~~assets ~~acquired~~and ~~entity~~liabilities and the ~~possibility~~tax ~~for~~rates ~~additional~~in ~~share~~effect ~~based~~when ~~payments~~these differences are expected to bereverse. ~~made~~A ~~within~~valuation 60allowance ~~days~~is ofprovided ~~receipt~~for ~~and~~certain ~~the~~deferred ~~results~~tax ofassets if it is more likely than not that the ~~report~~Company will not realize tax assets through future operations.

~~SolanAI~~The ~~Global~~loss ~~Ltd.~~from operation before income tax of the Company for the three months ended March 31, 2026 and March 31, 2025 were comprised of the following:

On August 25, 2025, the Company entered into a share exchange agreement with Crestar Holdings Ltd., wholly owned subsidiary of Goldfinch Group Holdings Ltd., and Hailiang Li for the acquisition of 51% equity interest in SolanAI Global Ltd. through the issuance of 10,000,000 restricted common shares as initial consideration. The Company may issue up to 5,000,000 additional shares based on independent SolanAI’s valuation completed within 120 days, subject to Board approval and additional SEC disclosure. On August 25, 2025, the Company issued 10,000,000 restricted shares of common stock at $1.25 with a fair value of $12,500,000 as initial consideration for the acquisition.

	For the			For the
	three months ended			three months ended
	March 31,			March 31,
	2026			2025
Tax jurisdiction from:	$			$
- Local		181,214			(77,045	)
- Foreign, representing:
China		92,578			(501	)
Hong Kong		(209,998	)		-
Income (Loss) before income taxes	$	63,794		$	(77,546	)

~~The~~18 ~~acquisition~~Table ~~was~~of ~~closed on August 25, 2025. SolanAI has been included in our consolidated balance sheets since the acquisition date.~~ Contents

~~The~~A ~~following~~reconciliation ~~table~~between ~~summarizes~~expected income taxes and the ~~preliminary~~income ~~liabilities~~tax ~~assumed~~net ~~upon~~expense ~~acquisition~~included in the statements of ~~SolanAI~~operations ~~and~~for the ~~calculation~~three ofmonths ~~goodwill~~ended March 31, 2026 and 2025 is as follows:

Total purchase price	$	12,500,000
	For the			For the
Total identifiable assets		-
	three months ended			three months ended
Other Payable		(2,252	)
	March 31, 2026			March 31, 2025
Total identifiable liabilities		(2,252	)
	Total			Total
Net assets (liabilities)		(2,252	)
Net income (loss) before income tax	$	(3,253,813	)	$	(486,397	)
Non-controlling interest		1,103
Statutory tax Rate		21	%		21	%
Total net assets (liabilities)		(1,149	)
Tax (benefit) expense at the statutory tax rate		(687,998	)		(102,163	)
Goodwill	$	12,501,149
Tax effect of
Stock-based compensation		696,697			85,859
Changes in valuation allowance		(8,700	)		16,304
Income tax expense (benefit) per book	$	-		$	-

The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the statutory rate to the income tax amount recorded as of March 31, 2026 and December 31, 2025, are as follows:

	March 31,			March 31,			March 31,			December 31,			December 31,			December 31,
	2026			2026			2026			2025			2025			2025
	USA			China/HK			Total			USA			China/HK			Total
Net operating loss carryforward	$	736,101		$	151,116		$	887,217		$	554,887		$	33,696		$	588,583
Statutory tax rate		21	%		25	%		21	%		21	%		25	%		21	%
Deferred tax asset		154,581			37,779			186,316			116,526			8,424			123,602
Less: Valuation allowance		(154,581	)		(37,779	)		(186,316	)		(116,526	)		(8,424	)		(123,602	)
Net deferred asset	$	-		$	-		$	-		$	-		$	-		$	-

The valuation allowance increased by $62,713 during the three months ended March 31, 2026. As of March 31, 2026, the Company had approximately $887,000 in net operating losses (“NOLs”) that may be available to offset future taxable income, which begin to expire between 2028 and 2036. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2018 through 2025 are subject to review by the tax authorities.

NOTE 10 – SEGMENT REPORTING

Operating segments ~~comprised~~ ofare ~~the~~ components of an entity infor which separate financial information is available ~~for~~and ~~evaluation~~evaluated by the Company’s chief operating decision maker, or(“CODM”) ~~group of decision makers,~~ in determining how to allocate resources inand ~~evaluating~~assess performance. The Company consists of a single reporting segment: AI technology services. This segment is comprised of the Company's efforts to provide advanced AI solutions and related strategic consulting services. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer.

~~Since~~As ~~September~~of ~~2024,~~March ~~the Company has focused on comprehensive strategic transformation and business restructuring efforts. This included establishing a new management team~~31, ~~defining a new AI-centric business direction~~2026, ~~and~~the ~~developing innovative AI-driven products and service portfolios. The~~ Company isoperates ~~actively~~through ~~building~~the afollowing ~~comprehensive~~reporting ~~AI ecosystem that integrates advanced AI Social Agent technology, multimodal intelligent interaction systems, and intelligent business process automation solutions.~~segments:

As· ofTechnology ~~September~~and ~~30,~~consulting ~~2025,~~services ~~the~~conducted ~~company~~through ~~reported~~Transuite.Org ~~revenue~~Inc.; of· ~~$100,000,~~Online ~~primarily~~medical ~~from~~education ~~strategic consulting~~ services toconducted ~~provide~~through ~~AI-Driven~~Solan ~~Ecosystem~~(Shenzhen) ~~Product~~Technology ~~to client~~Co., ~~During this period~~Ltd., wewhich ~~focused~~was acquired on ~~strategic~~September ~~transformation~~29, 2025; and ~~comprehensive~~· ~~business~~Intelligent ~~restructuring:~~infrastructure ~~Our~~and ~~newly~~e-bike ~~formed~~charging ~~core~~ management ~~team~~solutions ~~established~~conducted athrough ~~development~~Goldfinch-Chong ~~strategy~~(Fuzhou) ~~centered~~Technology ~~around AI Social Agent technology~~Co., ~~developing a series of innovative products and services around this focus~~Ltd.

~~With~~The ~~the~~Company’s ~~full~~chief ~~launch~~operating ofdecision ~~our~~makers ~~next-generation~~(“CODM”) AIare ~~Social~~the ~~Agent~~Chief ~~products,~~Executive weOfficers ~~anticipate~~and ~~driving~~Directors ~~sustained~~of ~~revenue~~the ~~growth~~respective ~~from AI technology services~~entities.

13Since ~~Table~~September 2024, the Company has undertaken strategic restructuring efforts, including reorganization of ~~Contents~~management functions and expansion into technology-driven service offerings. During the three months ended March 31, 2026, the Company’s primary operating activities consisted of strategic consulting and technology-related services, including business solution development and digital platform-related deliverables.

~~The~~For ~~accounting policies of~~ the ~~translation~~three ~~service~~months ~~segment~~ended ~~are~~March as31, ~~described~~2026 inand ~~the~~2025, ~~summary of significant accounting policies. The CODM will evaluate~~ the ~~performance of the translation service segment based on the~~ Company’s ~~net income (loss) as~~ reported inrevenue ~~the Statements~~ of ~~Operations~~$121,784 ~~upon~~and ~~resumption~~$0, ofrespectively. ~~the~~The ~~translation~~revenue ~~services.~~was ~~The~~primarily ~~Company’s~~derived ~~segment~~from ~~assets~~e-biking ~~are~~charging ~~reported~~solution and on-line ~~the~~medical ~~Balance Sheets~~education.

The ~~Company~~online ~~currently~~medical ~~focuses~~education onsegment ~~the~~commenced ~~cost~~operations ~~control~~following ~~and debt and equity financing to achieve its reorganization objective. Upon~~ the ~~resumption~~acquisition of ~~translation~~Solan ~~service,~~(Shenzhen) ~~the~~Technology ~~CODM will review performance based on gross profit~~Co., ~~operating~~Ltd. ~~profit,~~in ~~net~~September ~~earnings~~2025. ~~and~~The ~~net~~intelligent ~~earnings~~infrastructure ~~excluding~~segment ~~the~~related ~~impact~~to ofGoldfinch-Chong ~~the~~(Fuzhou) ~~fair~~Technology ~~value adjustment~~Co., ~~a non-GAAP financial measure~~Ltd. ~~Operating~~was ~~profit~~acquired ~~will~~on beDecember ~~reviewed~~31, ~~to monitor the operating and administrative expenses of the Company~~2025.

~~NOTE~~Management 11currently –focuses ~~COMMITMENT~~on ~~AND~~cost ~~CONTINGENCIES~~control, integration of acquired entities, and securing debt and equity financing to support ongoing business development. The CODM evaluates segment performance primarily based on operating results, including revenue and net income (loss). Segment assets are reported in the accompanying Consolidated Balance Sheets.

On19 ~~February~~Table 12, 2025, the Company entered into an agreement with 5D Partners LLC, a non-affiliate investment banker and financial advisor for fundraising, private placements, mergers and acquisitions and related services. The agreement commences on February 12, 2025, the effective date, and continues for a period of ~~12 months.~~Contents

~~The~~Segment ~~Company~~by ~~will~~Entity ~~issue~~and ~~common stock as follows:~~ Operations

	·	25,000 restricted common stock upon 6 months of the effective date (stock payable as of September 30, 2025); and
	·	25,000 restricted common stock upon 12 months of the effective date.

Three Months Ended March 31, 2026

On September 30, 2025, the Company entered into a share exchange agreement with Crestar Holdings Ltd. (Note 10) for the acquisition of XRS. The Company made an initial share payment valued at $1,700,000 and may issue additional shares subject to an independent valuation report. The contingent liability was calculated based on the net value of the XRS entity less the initial share payment. The Company has included a contingent liability of $22,875,281 pending the results of the report.

Entity	Transuite			Solan (Shenzhen)		Xirangsheng			Goldfinch HK		Goldfinch-Chong		SolanAI Global HK			Jiansheng & Yuan Qi			Goldfinch BVI & Crestar HK
Operation	Technology &			Online medical		Online health			Charging		E-bike		Web 3			AI Software			Corporate/
	Consulting			Education		Technology			Infrastructure		Charging		Infrastructure			Development			Holding		Total
Revenue	$	-		$	1,144	$	-		$	-	$	120,640	$	-		$	-		$	-	$	121,784
Cost of sales		-			-		-			-		12,160		-			-			-		12,160
Gross Profit	$	-		$	1,144	$	-		$	-	$	108,480	$	-		$	-		$	-	$	109,624

Segment Loss	$	(3,136,393	)	$	-	$	(383	)	$	-	$	93,251	$	(209,998	)	$	(290	)	$	-	$	(3,253,813	)

Total Assets	$	302,990		$	2,875	$	16,315		$	99	$	173,515	$	416		$	160		$	-	$	496,370

~~NOTE~~Three 12Months –Ended ~~SUBSEQUENT~~March ~~EVENTS~~31, 2025

In accordance with ASC 855, “Subsequent Events,” the Company has analyzed its operations subsequent to September 30, 2025 to the date these financial statements were issued and has determined that it has the below material subsequent event to disclose in these financial statements.

Entity	Transuite			Solan (Shenzhen)		Xirangsheng		Goldfinch HK		Goldfinch-Chong		SolanAI Global HK		Yuan Qi		Goldfinch BVI & Crestar HK
Operation	Technology &			Online medical		Online medical		Online medical		Online medical		Online medical		Software
	Consulting			Education		Education		Education		Education		Education		Development		Corporate			Total
Revenue	$	-		$	-	$	-	$	-	$	-	$	-	$	-	$	-		$	-
Cost of sales		-			-		-		-		-		-		-		-			-
Gross Profit	$	-		$	-	$	-	$	-	$	-	$	-	$	-	$	-		$	-

Segment Loss	$	(485,896	)	$	-	$	-	$	-	$	-	$	-	$	-	$	(501	)	$	(486,397	)

Total Assets	$	307,121		$	-	$	-	$	-	$	-	$	-	$	-	$	15,000		$	322,121

In20 ~~October~~Table ~~2025, the Company issued an aggregate~~ of ~~12,190,000 shares of common stock to consultants for service rendered valued at $4,618,045.~~Contents

OnSegment ~~October 14, 2025, the Company obtained written consent~~ by ~~the~~Geographical holders of the majority of the voting power of the Company's capital stock approving the adoption of the Company’s 2025 Stock Incentive Plan (the “Plan”). The Plan allows the Board of Directors of the Company to grant incentive stock options, nonqualified stock options and restricted stock awards to officers, directors, employees and consultants of the Company. At the time of consent, there were 7,000,000 shares of common stock of the Company reserved for issuance under the Plan. locations

14Three ~~Table~~Months ofEnded ~~Contents~~March 31, 2026

	USA			China		Hong Kong			Total
Revenue	$	-		$	121,784	$	-		$	121,784
Cost of sales		-			12,160		-			12,160
Gross profit		-			109,624		-			109,624

Total operating expenses		3,136,282			17,076		209,998			3,363,356

Loss from operations		(3,136,282	)		92,548		(209,998	)		(3,253,732	)

Other income (expenses)		(111	)		30		-			(81	)

Net loss	$	(3,136,393	)	$	92,578	$	(209,998	)	$	(3,253,813	)

As of March 31, 2026

	USA		China		Hong Kong		Total
Current Assets	$	302,990	$	151,141	$	515	$	454,646
Property and Equipment, net	$	-	$	41,724	$	-	$	41,724

Three Months Ended March 31, 2025

	USA			China			Hong Kong		Total
Revenue	$	-		$	-		$	-	$	-
Cost of sales		-			-			-		-
Gross profit		-			-			-		-

Total operating expenses		483,328			-			-		483,328

Loss from operations		(483,328	)		-			-		(483,328	)

Other income (expenses)		(2,568	)		(501	)		-		(3,069	)

Net loss	$	(485,896	)	$	(501	)	$	-	$	(486,397	)

As of March 31, 2025

	USA		China		Hong Kong		Total
Current Assets	$	269,818	$	15,000	$	-	$	284,818
Intangible Assets, net	$	37,303	$	-	$	-	$	37,303

Table of Contents

NOTE 11 – SUBSEQUENT EVENTS

In accordance with ASC 855, “Subsequent Events,” the Company has analyzed its operations subsequent to March 31, 2026 to the date these financial statements were issued and has determined that it has the below material subsequent event to disclose in these financial statements.

Authorized Share Increase

On March 10, 2026, the Company filed a Definitive Information Statement on Schedule 14C with the Securities and Exchange Commission relating to the approval of an Amended and Restated Articles of Incorporation to increase the number of authorized shares of common stock.

The amendment is expected to become effective upon filing with the Nevada Secretary of State following expiration of the applicable notice period. The Company is currently completing the related corporate filings.

On April 14, 2026, the Company filed Amended and Restated Articles of Incorporation with the Nevada Secretary of State, and the Amended and Restated Articles became effective upon filing.

Among other things, the Amended and Restated Articles amended and restated the Company’s articles of incorporation to provide that the total number of shares of capital stock that the Company is authorized to issue is 1,100,000,000 shares, consisting of (i) 1,000,000,000 shares of common stock, par value $0.001 per share, and (ii) 100,000,000 shares of preferred stock, par value $0.001 per share. The Amended and Restated Articles also include provisions relating to the authorization of preferred stock in one or more series, director and officer liability limitations, indemnification, certain opt-out elections under the Nevada Revised Statutes, bylaw authority, and forum selection for internal corporate actions.

Agreement with Williamsburg Venture Holdings, LLC

On May 21, 2026, the Company entered into a Prepayment Reimbursement and Stock Issuance Agreement with Williamsburg Venture Holdings, LLC and issued 66,667 restricted shares of common stock to Williamsburg. The shares were issued in full settlement of a $10,000 legal fee prepayment made on behalf of the Company.

Cooperation Agreement with AEEC

On March 10, 2026, the Company entered into a Cooperation Agreement with AEEC International Pty Ltd. (“AEEC”).Under the Agreement, TRSO, through Crestar Holdings Limited, intends to acquire 51% of AEEC, subject to the satisfaction of the conditions precedent. The conditions precedent mainly include completion of due diligence, receipt of AEEC’s required financial information, board approvals, and compliance with applicable regulatory and disclosure requirements. Management expects these conditions to be fulfilled during Q2 2026, subject to the progress of the required documents and procedures. As of March 31, 2026, the acquisition had not yet been completed. The 8,000,000 restricted shares will be issued only after the applicable closing conditions are satisfied. Under the Agreement, 4,000,000 shares will be issued to AEEC or its designated entities upon completion of closing, and the remaining 4,000,000 shares are management incentive shares, to be released in installments: 2,000,000 shares upon closing, 1,000,000 shares six months after closing, and 1,000,000 shares twelve months after closing. On May 28, 2026, 1,000,000 common shares were issued as management incentive shares.

Other Share Issuances

On June 1, 2026, the Company entered into a consulting agreement with Everpolar Int’l HK Holding Ltd. for non-exclusive corporate management and marketing service with a one year service term for consideration of 2,000,000 common shares issued on the execution date of the agreement.

From June 1 to June 3, 2026, the Company issued an aggregate of 6,500,000 common shares to non-affiliated consultants for services rendered.

Except as described above, the Company did not identify any additional material subsequent events requiring disclosure.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Transuite.Org Inc. (~~the~~ “~~Company~~TRSO,” ~~“we,”~~the “~~us,~~Company” ~~or “our”, Ticker: TRSO~~ ) iswas aincorporated ~~technology company focused on innovation~~ in the ~~artificial~~State ~~intelligence (AI) sector, having successfully completed a strategic transformation from a provider~~ of ~~traditional~~Nevada ~~language~~on ~~services~~June to15, ~~a provider of AI-driven solutions~~2018. The Company’s ~~mission~~common stock is toquoted ~~develop~~on ~~and~~the ~~deploy~~OTCQB ~~advanced~~market AIunder ~~technologies~~the ~~that~~ticker ~~empower~~symbol ~~clients~~“TRSO.” ~~across~~Our ~~various~~principal ~~industries~~website tois ~~enhance~~located ~~operational~~at ~~efficiency, strengthen customer engagement, and expand their global market reach~~https://www.transuite.org. The ~~Company~~information iscontained ~~led~~on, byor aaccessible ~~diverse~~through, ~~team~~our ofwebsite ~~international~~is ~~talent~~not ~~with~~incorporated ~~deep~~by ~~professional~~reference ~~expertise~~into ~~and~~this ~~international~~Annual ~~experience in AI, Web3~~Report.~~0, the Internet of Things (IoT), and financial technology.~~

~~The~~Historically, the Company ~~executes~~operated ~~its~~an AIonline ~~development~~translation ~~strategy~~and ~~through~~related ~~its~~service ~~wholly~~platform. During 2025, the Company undertook a strategic repositioning and expanded into a broader technology-~~owned~~focused holding company model through a series of acquisitions, subsidiary formations, ~~Goldfinch~~and ~~Group~~strategic ~~Holdings~~cooperation ~~Ltd~~arrangements. As a result, ~~and~~the ~~its~~Company ~~underlying~~is ~~holding~~now ~~structure~~focused on developing integrated solutions involving Web3 infrastructure, ~~which~~digital ~~provides~~asset atechnologies, ~~solid~~AI-enabled ~~organizational~~applications, ~~framework~~and ~~for~~intelligent ~~our~~infrastructure ~~technological~~systems. ~~integration~~Management believes that the convergence of digital finance, enterprise technology, and ~~global~~real-world ~~business~~infrastructure ~~expansion~~digitization may create long-term commercial opportunities across multiple markets.

~~Business~~During the year ended December 31, 2025, the Company generated revenue primarily from strategic consulting and ~~Strategy~~technology-related services supporting enterprise digital infrastructure initiatives. In addition, the Company continued to build its broader operating platform through acquisitions and strategic business expansion efforts. For the year ended December 31, 2025, the Company reported consolidated revenue of $117,765.

~~For~~Our the third quarter ended September 30, 2025, the Company got revenue from providing AI ecosystem-related products and consulting services. We believe this result provides an initial validation of the viability of our business model and the market demand for our solutions. The Company leverages its proprietary technology stack, including advanced AI models, big data analytics capabilities, and Web3/blockchain infrastructure, to establish a differentiated competitive advantage in the global market for intelligent customer support and cross-lingual automation services.Business

~~Recent~~The ~~Developments~~Company is a technology-focused holding company dedicated to developing and ~~Strategic~~integrating ~~Transactions~~business lines that combine enterprise technology services, Web3-related infrastructure, digital asset connectivity, and intelligent infrastructure management solutions. As of December 31, 2025, the Company’s operations were organized around the following principal business initiatives:

~~During~~SolanAI ~~the~~– ~~third~~Web3 ~~quarter~~Payment ~~of 2025, the Company pursued a series of strategic transactions to accelerate business growth~~ and ~~solidify~~Digital ~~its~~Asset ~~market position. These initiatives are designed to enhance our technological capabilities, broaden our product portfolio, and ultimately increase shareholder value.~~Infrastructure

~~Proposed~~Through ~~Material~~SolanAI ~~Acquisitions~~Global Ltd., a Hong Kong-based subsidiary, the Company is developing digital payment infrastructure intended to connect blockchain-based digital assets with real-world commercial payment environments. Management intends for this platform to support enterprise payment integration, cross-platform settlement capabilities, and digital asset-related transaction infrastructure.

	·	Proposed Transaction with Fujian Wochong Intelligent Technology Co., Ltd.: On September 15, 2025, the Company entered into an LOI to acquire a 51% equity interest in Fujian Wochong Intelligent Technology Co., Ltd. (“Wochong”), a National High-Tech Enterprise in China. Wochong specializes in intelligent electric vehicle (EV) charging solutions and possesses a comprehensive product portfolio, including high-end intelligent charging piles, charging security management systems, and an IoT and AI cloud platform. This proposed acquisition is intended to enable the Company to enter the rapidly growing EV charging market and to explore synergies between AI technology and IoT infrastructure, including the joint development of applications for the tokenization of charging assets as Real World Assets (RWAs). The consummation of this transaction is contingent upon the results of due diligence and execution of a definitive agreement
	·	Proposed Transaction with SYD GOLDX PTY LTD: On September 26, 2025, the Company entered into an LOI to acquire a 51% equity interest in SYD GOLDX PTY LTD (“SGX”), a licensed digital currency exchange in Australia. This proposed transaction is intended to integrate digital currency exchange functionalities into the Company’s existing technology ecosystem, with the goal of further strengthening our Web3 and fintech service capabilities. The consummation of this transaction is also contingent upon the results of due diligence and execution of a definitive agreement

AUXSTO – Digital Asset Exchange and Financial Infrastructure

~~Completed~~The ~~Material~~Company ~~Acquisition~~has entered into strategic cooperation arrangements with Australian Fintech Group Pty Ltd. and has also entered into an arrangement to acquire a 51% equity interest in AEEC International Pty Ltd., which operates under the brand name AUXSTO. Based on the Company’s current strategic plans, this initiative is intended to expand the Company’s capabilities in digital asset infrastructure, digital payment systems, trading platform technology, and cross-border financial technology services.

	·	Completion of the Acquisition of SolanAI Global Limited: On July 8, 2025, the Company entered into a Letter of Intent (LOI) to acquire a 51% equity interest in SolanAI Global Limited, a Hong Kong-based AI technology company(“SolanAI”). Subsequently, on August 25, 2025, the parties entered into a definitive Share Exchange Agreement. Pursuant to the agreement, the Company has issued restricted shares of its common stock as initial consideration and may issue up to an additional shares based on a future independent valuation of SolanAI. This transaction, which is subject to the satisfaction of closing conditions, is expected to strengthen the Company’s AI research and development capabilities and expand its presence in the Asian market upon completion
	·	Completion of the Acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd.: On September 30, 2025, the Company completed the acquisition of 100% of the equity of Xirangsheng (Shenzhen) Health Technology Co., Ltd. (“XRS”). XRS is an innovative enterprise that combines AI technology with Traditional Chinese Medicine (TCM) principles. Its core assets include an AI social agent based on a massive TCM knowledge base, a 21-day health supervision system, and a series of over 300 proprietary e-books on TCM health. This acquisition marks the Company’s official entry into the AI-driven wellness technology sector. The transaction was structured as a share exchange, with issued restricted shares of its common stock as initial consideration and includes an earn-out provision based on the future valuation of XRS

Goldfinch – Intelligent Infrastructure and Real-World Asset Integration

~~The~~Through ~~strategic~~Goldfinch ~~initiatives~~Group ~~described~~Co. ~~above~~Ltd. ~~reflect~~(Hong ~~the~~Kong) ~~Company’s commitment to building a diversified~~ and ~~vertically~~Goldfinch-Chong ~~integrated~~(Fuzhou) ~~AI-centric~~Technology ~~business~~Co., ~~ecosystem~~Ltd., Wethe ~~are~~Company ~~actively~~operates ~~pursuing~~intelligent ~~both~~infrastructure ~~horizontal~~systems ~~and~~focused ~~vertical~~on ~~industry integration with~~ the ~~aim~~management ~~of strengthening our technological barriers to entry, expanding our market penetration,~~ and ~~leveraging~~optimization ~~our~~of ~~corporate~~distributed ~~structure~~energy ~~to effectively integrate global resources~~ and ~~grow~~charging ~~our~~infrastructure ~~international footprint~~assets. ~~The~~This ~~proposed~~business ~~transactions~~line ~~are~~is ~~expected~~intended to ~~complete~~support ~~due~~data-driven ~~diligence~~asset ~~and~~management, ~~proceed~~infrastructure todigitization, ~~the~~and ~~definitive~~technology-enabled ~~agreement~~operation ~~stage~~of byreal-world ~~Dec~~infrastructure ~~31, 2025~~systems. ~~Our~~As ~~goal~~of isDecember to31, ~~increase~~2025, ~~value to meet~~ the ~~requirements~~Company toalso ~~uplist~~reported toinventory ~~Nasdaq~~associated orwith ~~NYSE~~e-bike ~~and~~charging ~~bring more benefits to our shareholders and contribute the society as well~~equipment.

~~Forward-Looking~~23 ~~Statements~~Table of Contents

~~This~~Technology Business section contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. These statements are based on our current expectations, assumptions, estimates, and ~~projections~~Consulting and involve known and unknown risks and uncertainties. Although we believe that the expectations reflected in these forward-looking statements are reasonable, actual results may differ materially from the results predicted in the forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements.Services

~~Outlook~~During 2025, the Company’s primary revenue-generating activities consisted of strategic consulting and technology-related services, including business solution development and digital platform-related deliverables. The Company’s segment reporting reflects technology and consulting services conducted through Transuite.Org Inc., online medical education services conducted through Solan (Shenzhen) Technology Co., Ltd., and intelligent infrastructure and e-bike charging management solutions conducted through Goldfinch-Chong (Fuzhou) Technology Co., Ltd.

We believe that the Company’s strategic transformation and recent strategic initiatives have established a foundation for our future growth and have positioned us favorably in the rapidly expanding AI market. In the future, we will focus on the successful integration of our acquired businesses, the continued development of innovative AI solutions, and the expansion of our global customer base. We believe that through our relentless pursuit of innovation, the leadership of our distinguished management team, and disciplined strategic execution, we are committed to creating long-term value for our shareholders.Strategy

15The ~~Table~~Company’s strategy is centered on building a diversified operating platform across enterprise technology, Web3-related infrastructure, digital asset enablement, and intelligent infrastructure systems. The principal elements of ~~Contents~~this strategy include:

~~Results~~1. ofStrategic ~~Operations~~Repositioning. ~~for~~The Company has transitioned from a legacy translation and consulting business into a broader technology-focused holding company platform. 2. Platform Development. The Company intends to continue developing business lines relating to digital payment infrastructure, AI-enabled applications, digital asset-related systems, and intelligent infrastructure management. 3. Business Integration. The Company is focused on integrating acquired subsidiaries and newly formed entities into a more scalable operating structure. 4. Market Expansion. Through subsidiaries, acquisitions, and strategic cooperation arrangements in the ~~three~~United ~~months~~States, ~~ended~~Hong ~~September~~Kong, 30mainland China, ~~2025~~and Australia, the Company seeks to expand commercial reach and ~~September~~develop 30international opportunities. 5. Capital and Partnership Development. Management intends to continue pursuing debt and equity financing, ~~2024~~strategic partnerships, and business combinations that may strengthen the Company’s capabilities and market position.

~~The~~Corporate ~~following summary of our operations should be read in conjunction with our audited financial statements for the three months ended September 30, 2025 and 2024, which are included herein.~~Development

	Three Months Ended
	September 30,
	2025		2024		Changes		%
Revenue	$	65,000	$	-	$	65,000		100	%
Operating Expenses		20,939,131		190,183		20,748,948		10,910	%
Other expenses		4,105		-		4,105		100	%
Net Loss	$	20,878,236	$	190,183	$	20,688,053		10,878	%

The following acquisitions and entity formations significantly expanded the Company’s operating structure during 2024 and 2025:

~~During~~On ~~the~~November ~~three months ended September 30~~24, ~~2025 and~~ 2024, the Company ~~generated revenue of $65,000~~ and ~~$0,~~other ~~respectively.~~founders ~~During~~formed ~~the~~Goldfinch ~~three~~Group ~~months~~Holdings ~~ended September 30~~Ltd., ~~2025,~~in which the Company ~~generated~~initially ~~revenue~~held ~~from~~a ~~its~~70% ~~AI-Driven~~controlling ~~Ecosystem Product Planning consulting service~~interest.

~~Net~~On ~~loss~~August ~~increased~~8, ~~to $20~~2025,~~878,236~~ ~~for~~ the ~~three~~Company ~~months~~entered ~~ended~~into ~~September~~a ~~30,~~share ~~2025~~exchange ~~from~~agreement ~~$190,183~~to ~~for~~acquire the ~~three~~remaining ~~months~~30% ~~ended~~equity ~~September~~interest 30in Goldfinch Group Holdings Ltd., ~~2024~~after ~~mainly~~which ~~due~~Goldfinch toGroup ~~the~~Holdings ~~increase~~Ltd. inbecame ~~operating~~a ~~expenses~~wholly owned subsidiary of the Company.

~~Operating~~On ~~expenses~~August ~~for three months ended September 30~~25, 2025 ~~increased to $20~~,~~939,131~~ ~~from $190,183 for~~ the ~~three~~Company ~~months~~completed ~~ended September 30, 2024 mainly due to~~ the ~~increase~~acquisition inof ~~stock-based~~51% ~~compensation,~~of ~~audit~~SolanAI ~~fees,~~Global ~~accounting fees and legal fees~~Ltd. ~~During~~through the ~~three months ended September 30, 2025, the Company incurred stock-based compensation of $20,828,790 from the~~ issuance of ~~11954~~10,000,000 ~~shares~~restricted of common ~~stock~~shares toas ~~consultants~~initial ~~for service rendered~~consideration.

~~Results~~On ofSeptember ~~Operations~~16, ~~for~~2025, ~~the~~Jiansheng ~~nine~~(Shenzhen) ~~months~~Technology ~~ended~~Co., ~~September~~Ltd. ~~30,~~was ~~2025~~formed ~~and~~as ~~September~~an ~~30,~~80% ~~2024~~subsidiary of Crestar Holdings Ltd.

~~The~~On ~~following~~September ~~summary~~29, of2025, ~~our~~Solan ~~operations~~(Shenzhen) ~~should~~Technology beCo., ~~read~~Ltd. inwas ~~conjunction~~formed ~~with~~as ~~our~~a ~~audited~~100% ~~financial~~subsidiary ~~statements~~of ~~for~~Crestar ~~the~~Holdings ~~six months ended September 30, 2025 and 2024, which are included herein~~Ltd.

	Nine Months Ended
	September 30,
	2025		2024		Changes		%
Revenue	$	115,000	$	-		115,000		100	%
Operating expenses		28,069,179		281,685		27,787,494		9,865	%
Other expenses		11,224		3,987		7,237		182	%
Net Loss	$	27,965,403	$	285,672	$	27,794,731		9,730	%

On September 30, 2025, the Company completed the acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd. through the issuance of 10,000,000 restricted common shares as initial consideration.

~~During~~On ~~the~~November ~~nine months ended September 30~~28, 2025 ~~and 2024~~, ~~the~~Yuan ~~Company~~Qi ~~generated~~(Shenzhen) ~~revenue~~AI ~~of $115~~Co.,~~000~~ ~~and $0, respectively~~Ltd. ~~During~~was ~~the~~formed ~~nine~~as ~~months~~a ~~ended~~100% ~~September~~subsidiary ~~30,~~of ~~2025,~~Crestar ~~the~~Holdings ~~Company generated revenue from its AI-Driven Ecosystem Product Planning consulting service~~Ltd.

~~Net~~On ~~loss~~December ~~increased~~31, ~~to $27~~2025,~~965,403~~ the Company entered into a share exchange agreement for the ~~nine~~acquisition ~~months~~of ~~ended~~51% ~~September~~of 30Goldfinch Group Co. Ltd. (Hong Kong), ~~2025~~which ~~from~~holds ~~$285~~100% of Goldfinch-Chong (Fuzhou) Technology Co.,~~672~~ ~~for~~Ltd. ~~the~~As ~~nine~~of ~~months~~December ~~ended~~31, ~~September~~2025, 303,500,000 ~~2024~~shares ~~mainly~~had ~~due~~been issued as initial consideration, with 1,500,000 additional shares to ~~the~~be ~~increase~~issued in ~~operating expense~~2026.

~~Operating~~As ~~expenses~~of ~~for~~December ~~nine months ended September 30~~31, 2025 ~~increased to $28~~,~~069,179~~ ~~from~~management ~~$281,685~~believed ~~for~~that the ~~nine~~Company ~~months~~had ~~ended~~completed ~~September~~a ~~30,~~substantial ~~2024~~portion ~~mainly~~of ~~due~~its tostrategic ~~the~~asset ~~increase~~integration inand ~~stock-based~~capital ~~compensation,~~structure ~~audit~~repositioning ~~fees, accounting fees~~ and ~~legal~~had ~~fees.~~established ~~During~~an ~~the~~initial ~~nine~~foundation ~~months~~for ~~ended~~future ~~September~~platform ~~30,~~commercialization ~~2025,~~and ~~the~~business ~~Company incurred stock-based compensation of $27,938,890 from the issuance of 15,570,000 shares of common stock to consultants for service rendered~~expansion.

1624 Table of Contents

Competition

The Company operates in competitive markets that include technology consulting, AI-enabled services, digital payment infrastructure, Web3-related systems, digital asset-related platform development, and intelligent infrastructure management. These markets are characterized by rapid technological change, evolving customer demand, and the presence of both established companies and emerging market participants.

The principal competitive factors affecting the Company’s business include product and platform development capability, quality and reliability of services, speed of execution, access to capital, management experience, strategic relationships, and the ability to navigate different regulatory and commercial environments.

Competitive Challenges

The Company faces a number of business and competitive challenges, including limited operating history in several of its newer business lines, the need to integrate acquired entities, competition from larger and more established market participants, dependency on external financing, and regulatory complexity associated with cross-border operations and digital infrastructure-related business initiatives. The Company’s future success will depend in part on its ability to execute its integration strategy, develop commercially viable platforms, and expand revenue-generating operations.

Intellectual Property

The Company seeks to protect its proprietary interests through applicable intellectual property laws, contractual protections, internal controls, and confidentiality arrangements, as appropriate. As of December 31, 2025, the Company reported website development and database-related intangible assets, net of accumulated amortization, in its consolidated balance sheet.

Regulation

The Company’s operations may be subject to various laws and regulations in the jurisdictions in which it conducts business, including those relating to corporate governance, securities reporting, cross-border operations, technology services, payments, digital assets, data handling, and other commercial activities. As the Company continues to develop its business lines, it may become subject to additional laws, regulations, licensing requirements, and compliance obligations in the United States and other jurisdictions.

Results of Operations for the three months ended March 31, 2026 and March 31, 2025

Results of Operations

The following summary of our operations should be read in conjunction with our audited financial statements for the three months ended March 31, 2026 and 2025, which are included herein.

	Three Months Ended
	March 31,
	2026		2025		Changes			%

Revenue	$	121,784	$	-	$	121,784			100	%
Operating expenses		3,363,356		483,328		2,880,028			596	%
Other expenses		81		3,069		(2,988	)	(97		)%
Net Loss	$	3,253,813	$	486,397	$	2,877,040			592	%

Table of Contents

During the three months ended March 31, 2026 and 2025, the Company generated revenue of $121,784 and $0, respectively. During the three months ended March 31, 2026, the Company generated revenue from it 51% owned subsidiary Goldfinch-Chong Technology Co., Ltd.’s e-bike charging management solutions of $120,640 and its wholly owned subsidiary Solan (Shenzhen) Technology Co., Ltd.’s online medical education of $1,144, respectively.

Net loss increased during the three months ended March 31, 2026 mainly due to the increase in operating expense.

Operating expenses increased during the three months ended March 31, 2026 primarily due the increases in stock-based compensation, audit fees and accounting fees. During the three months ended March 31, 2026, the Company recorded total stock-based compensation of $3,317,607.

Liquidity and Capital Resources

The following table provides selected financial data about the Company as of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025

Working Capital

	As of		As of
	September 30,		December 31,
	March 31,		December 31,
	2025		2024			Changes			%
	2026		2025			Changes			%
Current Assets	$	~~299~~454,~~842~~646	$	31320,~~103~~301		$	~~268~~134,~~739~~345			~~864~~42	%
Current Liabilities	$	~~153~~345,~~042~~749	$	~~225~~809,~~294~~897		$	(72464,~~252~~148	)	(3257		%)%
Working Capital (Deficiency)	$	~~146~~108,~~800~~897	$	(~~194~~489,~~191~~596	)	$	~~196~~(329,~~487~~803	)	~~(101~~	67	%)

As at ~~September~~December 3031, 2025, our Company had a working capital of $~~146~~108,~~800~~897 compared with a working capital deficiency of $~~194~~489,~~191~~596 as at December 31, ~~2024~~2025. The increase in working capital was primarily due to the increase in ~~deferred share issuance cost of $254,750,~~ accounts receivable ~~of $15,000~~ and ~~other~~prepaid ~~receivable~~expense and ~~prepayment of $16,062 and~~ the decrease in ~~convertible~~stock ~~note of $153,250~~payable.

Cash Flows

~~Nine~~Year ~~months~~Ended ~~ended~~December ~~September 30~~31, 2025 compared to the ~~nine~~year ~~months~~ ended ~~September~~December 3031, 2024:

	Nine Months Ended
	Three Months Ended
	September 30,
	March 31,
	2025			2024			Changes			%
	2026			2025			Changes			%
Cash flows used in operating activities	$	(285,~~209~~484	)	$	(~~123~~72,~~877~~146	)	$	9566,~~668~~662		(7792		%)%
Cash flows provided by investing activities		1(26,~~458~~521	)		-			1(26,~~458~~521	)		100	%
Cash flows provided by financing activities		2433,~~678~~427			~~163~~56,~~625~~426			(~~138~~22,~~947~~999	)	(8541		%)%
Net changes in cash	$	~~(2,073~~840	)	$	39(15,~~748~~720	)	$	~~(41~~17,~~821~~142	)	(~~100~~109		%)%

Table of Contents

Cash Flow from Operating Activities

We have not generated positive cash flow from operating activities. During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, net cash used in operating activities was $285,~~209~~484 compared to $~~123~~72,~~877~~146 used during the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2026.

Cash flows used in operating activities during the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, comprised of a net loss of $273,~~965~~253,~~403~~813, which was reduced by ~~amortization~~total stock-based compensation of $93,~~684~~317,607and ~~stock-based~~depreciation ~~compensation~~ of $272,~~938~~196,~~890~~ and was increased by net changes in operating assets and liabilities of $1171,~~380~~474.

Cash flows used in operating activities during the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, comprised of a net loss of $~~285~~486,~~672,~~397 which was reduced by ~~amortization~~stock-based compensation of $9408,~~842,~~851 ~~imputed~~and ~~interest~~amortization of $3,~~321~~228 and net changes in operating assets and liabilities of $~~148~~2,~~632~~172.

Cash Flow from Investing Activities

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, the Company ~~received~~acquired ~~$1,458~~equipment ~~from net funds from acquisition~~ of ~~Xirangsheng (Shenzhen) Health Technology Co.~~$26, ~~Ltd~~521.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, we did not have any investing activities.

17 Table of Contents

Cash Flow from Financing Activities

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024~~2025, we had net cash provided by financing activities of $2433,~~678~~427 and $~~163~~56,~~625~~426, respectively.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, we received advancement from non-affiliates of $5340,~~620~~692 ~~offset~~and byadvancement ~~repayment~~from to the ~~non-affiliate~~director of ~~$30,000,~~Xirangsheng ~~and~~(Shenzhen) ~~advancement~~Health ~~from~~Technology ~~the directors of $25~~Co.,~~058~~ ~~for~~Ltd. ~~payment~~and ~~made~~Solan to(Shenzhen) ~~vendors~~Technology onCo., ~~behalf~~Ltd. of ~~the~~$27,158 ~~Company~~ offset by repayment to the director of Transuite of $2410,~~000~~900.

During the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, we received advancement from on-affiliates of $46,820 and advancement from the former director of Transuite of $~~163~~2,~~625~~154 for payment made to vendors on behalf of the Company.

Going Concern

As of ~~the~~March ~~nine months ended September 30~~31, ~~2025~~2026, we had an accumulated deficit of $2840,~~429~~815,~~710~~538 and negative operating cash flow of $285,~~209~~484 for ~~nine~~the three months ended ~~September~~March 3031, ~~2025~~2026. Management notes, however, that a substantial portion of the Company’s reported operating expenses for three months ended March 31, 2026 consisted of non-cash items, including stock-based compensation, which did not have a corresponding impact on near-term operating cash flows.

~~While~~The ~~TRSO~~Company's ~~continues~~ability to ~~invest~~continue ~~heavily~~as ina ~~its~~going ~~transformative~~concern ~~growth~~is ~~strategy~~contingent upon achieving future profitable operations and securing sufficient financing to meet operational obligations. Management plans to fund operations over the next twelve months through existing cash resources, related party support, additional debt or equity financing, and potential capital raises via public or private offerings. Management is actively pursuing these financing and business development initiatives and believes that such efforts, together with ongoing strategic expansion and liability management measures, may support the Company’s ~~has~~operations ~~demonstrated~~over ~~significant~~the ~~progress~~next twelve months. However, there can be no assurance that the Company will be successful in ~~strengthening~~obtaining ~~its~~sufficient ~~financial~~financing ~~foundation~~or ~~and~~achieving ~~operational~~profitable ~~capabilities~~operations.

~~The~~To ~~improvement~~improve inits ~~working~~financial ~~capital from a deficit of $194~~position,~~191~~ ~~to a positive $146,800 reflects effective financial management and successful execution of~~ the ~~business~~Company ~~transformation. Management~~ has implemented a comprehensive strategy focused on ~~accelerating revenue growth through expanded client relationships, strategic acquisitions to enhance technology offerings, and systematic intellectual property development.~~ :

~~With~~1. ~~committed~~Revenue ~~funding~~Growth of– upexpanding tostrategic ~~$10~~consulting, ~~million~~enterprise ~~available~~technology, ~~through~~and ~~the~~infrastructure-related ~~Williamsburg~~service ~~agreement~~opportunities; 2. Strategic Expansion – integrating acquired businesses and ~~strong~~developing ~~early~~scalable ~~revenue~~Web3, ~~generation~~digital ~~demonstrating~~asset, ~~market~~and ~~validation~~infrastructure platforms; 3. Market Development – building strategic partnerships and expanding commercial relationships across multiple jurisdictions; 4. Technology Advancement – strengthening platform capabilities, ~~TRSO~~intellectual isproperty ~~well-positioned~~development, toand ~~achieve~~commercialization ~~sustainable~~readiness. ~~profitability~~5. Capital Structure and ~~deliver~~Liquidity ~~exceptional~~Management ~~returns~~– topursuing ~~shareholders~~equity asand ~~the~~debt AIfinancing ~~market~~opportunities, ~~continues~~related ~~its~~party ~~rapid~~support, ~~expansion~~strategic capital arrangements, and liability restructuring where appropriate.

Table of Contents

Management believes these initiatives will support long-term financial improvement and future business expansion. The Company will continue to monitor and report on their operational and financial progress.

Management notes that a substantial portion of the Company’s operating expenses for the three months ended March 31, 2026 consisted of non-cash stock-based compensation associated with strategic services, corporate restructuring, and platform expansion initiatives. Management believes the Company’s 2026 financial results should be evaluated in the context of its broader strategic repositioning and non-cash capitalization activities.

Management believes that 2026 should be evaluated as a strategic repositioning and platform-buildout year, during which a significant portion of reported operating expense was non-cash in nature. Management further believes that the strategic acquisitions, platform development efforts, and financing initiatives undertaken during and after three months ended March 31, 2026 provide an initial foundation for future commercialization, revenue expansion, and improved operating scale.

Off Balance Sheet Arrangements

We have no off-balance sheet arrangements including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

Critical Accounting Policies

The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements’ estimates or assumptions could have a material impact on our financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. Our financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.

Fair Value of Financial Instruments

ASC 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

These tiers include:

Level 1: defined as observable inputs such as quoted prices in active markets;

Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and

Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

18 Table of Contents

The carrying value of cash, prepayments and the Company’s loan from shareholder approximates its fair value due to their short-term maturity.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, “Revenue Recognition” following the five steps procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when the entity satisfies a performance obligation

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued. Our Company’s management believes that these recent pronouncements will not have a material effect on our financial statements. Refer to Note 2 in the accompanying consolidated financial statements.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the SEC’s rules. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of ~~September~~March 3031, ~~2025~~2026. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of ~~September~~March 3031, ~~2025~~2026.

Our disclosure controls and procedures reflect the company’s current stage of development and organizational structure. Currently, our Chief Executive Officer and Director assumes core responsibility for financial processes, including the identification, authorization, approval, accounting for, and disclosure of significant estimates, related-party transactions, and unusual transactions. We are evaluating and planning to implement additional control measures, including the introduction of independent review mechanisms, to further enhance the effectiveness and reliability of our internal controls.

Changes in Internal Control Over Financial Reporting

During the period covered by this report there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Internal Controls

Our management do not expect that our disclosure controls and procedures or our internal control over financial reporting are or will be capable of preventing or detecting all errors or all fraud. Any control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements, due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns may occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risk.

1929 Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 1A. Risk Factors

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

~~During~~On ~~the~~January ~~three months ended September 30~~2, ~~2025~~2026, the Company issued an2,140,016 ~~aggregate~~common shares for the settlement of ~~11,954,000~~loan ~~shares~~payable of ~~common~~$128,401 ~~stock~~in pursuant to ~~consultants~~the ~~for~~settlement ~~service~~agreement ~~rendered~~entered ~~valued~~on atDecember ~~$20~~3,~~828,790~~ 2025. (Note 5)

On ~~August~~January 2016, ~~2025~~2026, the Company issued 3666,~~000,000~~666 ~~shares of~~ common ~~stock~~shares atfor ~~$2.00~~the ~~per~~settlement ~~share~~of ~~with~~ a ~~fair~~trade ~~value~~payable of $640,000~~,000~~ toin ~~acquire~~pursuant to the ~~remaining~~settlement ~~30%~~agreement ~~equity~~entered ~~interest~~on inDecember ~~Goldfinch~~3, ~~Group~~2025. ~~Holdings~~(Note ~~Ltd.~~5)

On ~~August~~March ~~25,~~31 ~~2025~~2026, the Company issued 10342,~~000,000~~216 ~~shares of~~ common ~~stock~~shares atfor ~~$1.25~~the ~~per~~settlement ~~share~~of ~~with~~loan apayable ~~fair value~~ of $1220,~~500,000~~533 asin ~~initial~~pursuant ~~consideration~~to ~~for~~ the ~~acquisition~~settlement ofagreement ~~51%~~entered ~~equity~~on ~~interest~~December in3, ~~SolanAI Global Ltd~~2025. (Note 5)

OnFrom ~~September~~January 30to February 2026, ~~2025~~3,500,000 ~~the~~common ~~Company~~shares were issued ~~10,000,000~~as ~~restricted~~partial ~~shares~~consideration for the acquisition of ~~common~~51% ~~stock~~equity atinterest $0in Goldfinch Group Co.17 ~~per~~Ltd. ~~share~~(Hong ~~with~~Kong) ain ~~fair~~pursuant ~~value~~to ofshare ~~$1,700,000~~exchange asagreement ~~initial~~entered ~~consideration~~on ~~for~~December ~~the~~31, ~~acquisition~~2025. The remaining consideration of ~~100%~~1,500,000 ~~equity~~common ~~interest~~shares inwill ~~Xirangsheng~~be ~~(Shenzhen)~~issued ~~Health~~within ~~Technology~~year Co2026., ~~Ltd.~~

Pursuant to a cooperation agreement entered with Honwo Technology Holding Limited (“Honwo”) to establish a strategic collaboration framework in Web3 technology and related business development on February 21, 2026, the Company issued 1,000,000 restricted common shares to Honwo as incentive shares valued at $190,000 on February 24, 2026.

On February 23, 2026, pursuant to the agreement signed on February 21, 2026, the Company issued 3,000,000 common shares to Solan AI Global Ltd for strategic support shares valued at $600,000. The shares were recorded as treasury stock in the Balance Sheet.

From January to February 2026, the Company issued an aggregate of 1,550,000 common shares valued at $155,000 to consultants for service rendered.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

Item 6. Exhibits

31.1		Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act

32.1		Certification of Chief Executive Officer and Chief Financial Officer Under Section 1350 as Adopted Pursuant Section 906 of the Sarbanes-Oxley Act

2030 Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

Transuite.Org Inc.

Dated November 18, 2025	By:	/s/ Mengqing Fan
Dated June 16, 2026	By:	/s/ Mengqing Fan
		Mengqing Fan
		Title: CEO, Director
		Title: CEO, Director, Chairwoman of the Board

Dated November 18, 2025	By:	/s/ Wei Zhen
Dated June 16, 2026	By:	/s/ Hailiang Li
		Wei Zhen
		Hailiang Li
		Title: CFO, Director
		Title: CFO

2131

Filing Compare · TRANSUITE.ORG INC.